![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Report : A-Z of formulary items 08/03/2021 10:18:17 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[Back] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
01.07.04 |
Diltiazem Cream 2% |
Unlicensed med Only if glyceryl trinitrate tried and not tolerated or ineffective 08.02.04 |
Dimethyl fumarate caps |
Must be prescribed as Tecfidera 13.05.03 |
Dimethyl fumarate tabs |
Must be prescribed as Skilarence 13.10.04 |
Dimeticone 4% lotion |
Can be bought OTC Use in combination with wet combing 07.01.01 |
Dinoprostone |
1st line for induction of labour See below for NICE guidelines “Induction of Labour” Available as
14.04 |
Diphtheria antitoxin |
| 14.04 |
Diphtheria vaccines for Children Under 10 years |
| 02.09 |
Dipyridamole |
Dipyridamole is currently considered formulary with some usage within cardiology and Stroke services. 11.11 |
Disodium Edetate (EDTA) 0.37% eye drops |
Unlicensed special 20 |
Disodium edetate EDTA 0.37% drops |
Available as
06.06.02 |
Disodium Pamidronate |
| 02.03.02 |
Disopyramide caps |
| 13.05.02 |
Dithranol |
Available as
Use only on advice of a specialist On initiation prescribe all four (0.25%, 0.5%, 1%, 2%) titration strengths on initial prescription – only one prescription charge for patient 02.07.01 |
Dobutamine |
| 08.01.05 |
Docetaxel |
| 01.06.02 |
Docusate caps,solution,enema |
Capsules available OTC 05.03.01 |
Dolutegravir |
| 05.03.01 |
Dolutegravir, abacavir & lamivudine Triumeq® |
| 04.06 |
Domperidone tabs,suspension |
MHRA:Risk of cardiac side effects MHRA:Minimising risk of cardiac side effects with apomorphine Use restricted to nausea and vomiting only. The maximum treatment duration should not usually exceed one week. 04.11 |
Donepezil Aricept® |
Initiated and stabilised by secondary care 02.07.01 |
Dopamine |
| 03.07 |
Dornase Alfa Pulmozyme® |
Commissioned by NHSE. Do not prescribe in primary care for new patients (since April 2013) At Ipswich hospital - to be supplied by Addenbrokes on homecare At Colchester hospital - not to be supplied unless confirmation of funding achieved (existing patients should utilise their own previosly funded supply) 11.06 |
Dorzolomide 2% |
Available as
11.06 |
Dorzolomide and Timolol |
Available as 2% / 0.5% in
03.05.01 |
Doxapram |
| 15.01.07 |
Doxapram injection |
| 02.05.04 |
Doxazosin |
MR tablets are non-formulary Hospital only guidanceSwitching from MR to IRSee below for guidance
Primary care guidanceSwitching from MR to IRConsider one of the following regimens
See below for more information 07.04.01 |
Doxazosin |
| 08.01.02 |
Doxorubicin |
| 08.01.02 |
Doxorubicin Liposomal |
| 08.01.02 |
Doxorubicin Hydrochloride injection |
| 02.03.02 |
Dronedarone Multaq® |
| 04.06 |
Droperidol |
Hospital only – post-operative nausea and vomiting in PCA 06.01.02.03 |
Dulaglutide |
| 04.07.03 |
Duloxetine Cymbalta® |
Traffic light information
07.04.02 |
Duloxetine Yentreve® |
| 08.01.05 |
Durvalumab Imfinzi |
| 06.04.02 |
Dutasteride Avodart® |
Consultant urologist only for following scenarios
or
02.08.02 |
Edoxaban |
Traffic light information
20 |
Edrophonium 10mg/ml injection |
| 10.02.01 |
Edrophonium Chloride injection |
| 05.03.01 |
Efavirenz Sustiva® |
| 13.09 |
Eflornithine cream |
If COCs are contraindicated or have not worked Discontinue if no benefit is seen within 4 months of starting treatment and refer to secondary care
NEECCG - Eflornithine is non-formulary 13.09 |
Eflornithine cream |
Discontinue if no benefit is seen within 4 months of starting treatment and refer to secondary care 05.03.03.02 |
Elbasvir/Grazoprevir Zepatier® |
| 06.04.01.01 |
Elleste-Duet estradiol 2mg + norethisterone acetate 1mg |
Note- there are 2 preparations with different strengths of estradiol 06.04.01.01 |
Elleste-Duet estradiol 1mg+ norethisterone acetate 1mg |
Note- there are 2 preparations with different strengths of estradiol 09.01.04 |
Eltrombopag tabs |
MHRA:Reports of interference with bilirubin and creatinine test results 01.04.02 |
Eluxadoline |
|
Ipswich Hospital the drug is approved and is considered formulary but the Traffic Light status of the product is to be confirmed. Colchester Hospital The drug is approved and is considered formulary. Secondary care initiation is followed by a formal review after 4 weeks treatment; at which point prescribing is transferred to Primary Care colleagues if treatment is to continue. 05.03.01 |
Elvitegravir |
| 13.03 |
Emollients |
Pruritus associated with dry skin or for pruritus in otherwise healthy elderly people Click here to see preparations used as emollients 13.05.01 |
Emollients |
Click here to see preparations used as emollients 13.08.01 |
Emollients |
Click here to see preaprations used as emollients Photograph area before treatment Refer if there is ulceration or induration Ensure that the patient is aware it will look much worse before it heals. 13.02.01 |
Emollin ® |
Only on advice from specialist where
06.01.02.03 |
Empagliflozin |
| 05.03.01 |
Emtricitabine Emtriva® |
| 05.03.01 |
Emtricitabine + tenofovir alafenamide Descovy® |
| 05.03.01 |
Emtricitabine 200mg, Rilpivirine 25mg and Tenofovir 245mg Eviplera® |
| 13.02 |
Emulsifying Ointment BP |
Can be bought OTC 05.03.01 |
Enfuvirtide Fuzeon® |
| 02.08.01 |
Enoxaparin |
| 02.01.02 |
Enoximone |
Hospital ITU only 04.09.01 |
Entacapone |
| 05.03.03.01 |
Entecavir Baraclude |
| 08.01.05 |
Entrectinib Rozlytrek® 100mg and 200mg |
| 08.03.04.02 |
Enzalutamide caps |
| 02.07.02 |
Ephedrine |
Hospital ITU or anaesthesia only 12.02.02 |
Ephedrine nasal drops |
Available OTC 13.02.01 |
Epimax ® |
Can be bought OTC
Equivalent to Diprobase® Cream Can be used as a soap substitute
As of March 2020 Epimax cream has been renamed Epimax Original cream. 08.01.02 |
Epirubicin |
| 02.02.03 |
Eplerenone |
Usually specialist initiation within Secondary Care setting, but for heart failure, treatment can also be initiated under the supervision/recommendation of a Consultant Cardiologist, General Practitioners with a Special Interest in Cardiology or Heart Failure Specialist Nurses 09.01.03 |
Epoetin alfa Eprex® |
Traffic light information
09.01.03 |
Epoetin beta NeoRecormon® |
Traffic light information
02.08.01 |
Epoprostenol |
Ipswich Hospital Neonatal unit use only Colchester Hospital Usage limited to Critical Care practice 09.06.04 |
Ergocalciferol |
| 20 |
Ergocalciferol 20,000 units in 1ml oral solution |
| 07.01.01 |
Ergometrine injection |
Initial management of post partum haemorrage 07.01.01 |
Ergometrine Maleate and Oxytocin |
Active management of 3rd stage of labour Initial management of PPH
08.01.05 |
Eribulin injection |
| 06.01.02.03 |
Ertugliflozin Steglatro |
Ipswich diabetes consultants prefer other choices in this class of drugs. Awaiting cardiovascular outcome data. 13.06.02 |
Erythromycin |
Only if tetracyclines not tolerated. 13.06.03 |
Erythromycin |
Only if tetracyclines are contraindicated 02.04 |
Esmolol injection |
| 07.02.01 |
Estradiol 10mcg vaginal tablet |
| 08.01.01 |
Estramustine Phosphate caps |
| 06.04.01.01 |
Estriol 0.01% cream |
| 07.02.01 |
Estriol 0.01% cream |
| 06.04.01.01 |
Estriol 0.1% cream |
| 07.02.01 |
Estriol 0.1% cream |
| 02.11 |
Etamsylate |
Palliative care use only 10.01.03 |
Etanercept |
Prescribing etanercept at Ipswich and Colchester hospitals
13.05.03.02 |
Etanercept |
Consultant dermatologists & rheumatologists only Hospital only guidancePrescribing etanercept
Should patients experience unexpected side effects, lack of tolerance or a symptom flare while using the biosimilar, the originator product i.e Enbrel® should be used 09.05.01.02 |
Etelcalcetide Parsabiv® |
| 11.11 |
Ethanol 18% |
Unlicensed special Preservative free drops 06.04.01.01 |
Ethinylestradiol |
| 07.03.01 |
Ethinylestradiol / levonorgestrel phased pill |
Phasic standard strength with the following strengths for each phase - 30mcg/50mcg - 40mcg/75mcg - 30mcg/125mcg
Available as 21 day and 28 day preparations 07.03.01 |
Ethinylestradiol 20 mcg / drospirenone 3 mg |
Standard strength For family planning clinic use only - supplied by IHT 07.03.01 |
Ethinylestradiol 20 mcg / norethisterone 1mg |
low strength 07.03.01 |
Ethinylestradiol 20mcg / desogestrel 150mcg Gedarel®, Mercilon® |
Ipswich Hospital Ethinylestradiol 20mcg / desogestrel 150mcg is a non-formulary medicine Colchester Hospital / NEECCG Ethinylestradiol 20mcg / desogestrel 150mcg is considered a formulary medicine choice 07.03.01 |
Ethinylestradiol 20mcg / gestodene 75 mcg Millinette®, Femodette®, Juliperla® |
Ipswich Hospital Ethinylestradiol 20mcg / gestodene 75 mcg is a non-formulary medicine Colchester Hospital / NEECCG Ethinylestradiol 20mcg / gestodene 75 mcg is considered a formulary choice 20 |
Ethinylestradiol 2mcg tabs |
| 07.03.01 |
Ethinylestradiol 30 mcg / drospirenone 3 mg Yasmin® |
Ipswich Hospital Ethinylestradiol 30 mcg / drospirenone 3 mg (Yasmin) is a non-formulary medicine Colchester Hospital / NEECCG Ethinylestradiol 30 mcg / drospirenone 3 mg (Yasmin) is considered a formulary medicine choice (to be utilised only if the patient has associated androgenic skin problemns) 07.03.01 |
Ethinylestradiol 30 mcg /desogestrel 150 mcg |
low strength 07.03.01 |
Ethinylestradiol 30mcg / gestodene 75 mcg |
standard strength 07.03.01 |
Ethinylestradiol 30mcg / levonorgestrel 150mcg |
standard strength 07.03.01 |
Ethinylestradiol 35 mcg / noresthisterone 1mg |
standard strength 07.03.01 |
Ethinylestradiol 35 mcg / noresthisterone 500mcg |
standard strength 07.03.01 |
Ethinylestradiol 35 mcg / norgestimate 250 mcg |
Standard strength For family planning clinic use only - supplied by IHT
North East Essex CCG Ethinylestradiol 35mcg/ norgestimate 250mcg is considered a formulary medicine choice. 04.08.01 |
Ethosuximide |
| 15.02 |
Ethyl Chloride spray |
| 10.01.01 |
Etodolac MR tabs |
Ipswich Hospital Etodalac is approved for use to treat Rheumatoid Arthritis and Osteoarthritis only Colchester Hospital / NEECCG Etodalac is considered a non-formulary medicine 07.03.02.02 |
Etonorgestrel Nexplanon® |
MHRA:Reports of device in vasculature and lung MHRA: New insertion site to reduce rare risk of neurovascular injury and implant migration Remove after 3 years 08.01.04 |
Etoposide caps, injection |
| 10.01.01 |
Etoricoxib |
MHRA:Revised dose recommendation for rheumatoid arthritis and ankylosing spondylitis Ipswich Hospital Second-line use to treat Rheumatoid Arthritis, Osteoparthritis and Ankolysing Spondylitis Colchester Hospital Etoricoxib has limited use as a second line agent. 13.02.01 |
Eucerin ® Intensive |
Usually only on advice from specialist 08.01.05 |
Everolimus Afinitor® |
| 02.12 |
Evolocumab Repatha® |
Ipswich Hospital Treatment will only be initiated by a clinical pathologist in the lipid clinic Colchester Hospital Evolocumab is considered non-formulary. All persepctive patients are referred to the Ipswich lipid clinic. 06.04.01.01 |
Evorel Conti estradiol ~50mcg/24hrs + norethisterone acetate ~170mcg/24hrs |
Reserved for patients unable to swallow 06.04.01.01 |
Evorel Sequi estradiol ~50mcg/24hrs + norethisterone acetate ~170mcg/24hrs |
| 08.03.04.01 |
Exemestane |
| 06.01.02.03 |
Exenatide Byetta▼® |
Ipswich Hospital Exenatide is considered non-formulary Colchester Hospital Exenatide is considered a formulary medicine; although rarely used and with treatment initiation by a Consultant Endocrinologist only 06.01.02.03 |
Exenatide prolonged release Bydureon® |
Not for new initiations, treatment continuation only 13.05.02 |
Exorex Coal tar solution 5% |
Can be bought OTC Coal tar shampoos should not be used alone for people who have severe scalp psoriasis 13.06.03 |
Eyelid hygiene measures |
| 02.12 |
Ezetimibe |
Very limited usage. Only to be utilised in accordance with NICE guidance. 10.01.04 |
Febuxostat Adenuric® |
MHRA: Stop treatment if signs or symptoms of serious hypersensitivity 02.06.02 |
Felodipine |
| 06.04.01.01 |
Femoston estradiol 1 mg+ dydrogesterone 10 mg |
| 06.04.01.01 |
Femoston estradiol 2 mg+ dydrogesterone 10 mg |
| 06.04.01.01 |
Femseven Conti estradiol ~50mcg/24hrs + levonorgestrel ~7mcg/24hrs |
Reserved for patients unable to swallow 06.04.01.01 |
Femseven Sequi estradiol ~50mcg/24hrs + levonorgestrel ~10mcg/24hrs |
| 02.12 |
Fenofibrate |
Only if intolerant to statins 04.07.02 |
Fentanyl |
MHRA:Potential for life-threatening harm from accidental exposure
MHRA:Life-threatening and fatal opioid toxicity from accidental exposure, particularly in children Reserved for end of life care and patients with Parkinsons / severe dysphagia Hospital only guidanceInitiationOnly to be initiated by either
15.01.04.03 |
Fentanyl |
| 04.07.02 |
Fentanyl sublingual tablets Abstral® |
Joint guidanceLow Clinical Value MedicineStrictly for the management of breakthrough pain for chronic cancer pain Fentanyl immediate release (Abstral) MUST NOT be initiated within primary care
09.01.01.02 |
Ferric Carboxymaltose Ferinject® |
Whereas iron dextran (Cosmofer) is the iron infusion of choice for hospital in-patients for whom discharge is not imminent, ferric carboxymaltose (Ferinject) - with its shorter infusion time - can be utilised in clinical areas with high turnover of patients (e.g. renal, haematology, maternity, etc) and within hospital in-patients areas where a quicker administration of an iron infusion will facilitate discharge (e.g. Emergency Assessment Unit).
09.01.01.01 |
Ferrous Fumarate |
The 210mg tab is for primary care use only Available as
09.01.01.01 |
Ferrous Gluconate |
Avaiable as
09.01.01.01 |
Ferrous Sulphate |
Available as
07.04.02 |
Fesoterodine Toviaz® |
Ipswich Hospital Fesoterodine is a non-formulary medicine Colchester Hospital / NEECCG Fesoterodine is considered a formulary choice (third line therapy) 03.04.01 |
Fexofenadine |
Only if other antihistamines ineffective or not tolerated 06.01.01.01 |
Fiasp® Insulin Aspart |
Rapid acting insulin anologue Note : Faster acting than Novorapid Available as:
05.01.07 |
Fidaxomicin Dificlir® |
Traffic light information
09.01.06 |
Filgrastim |
| 06.04.02 |
Finasteride |
| 06.01.06 |
FineTest Lite |
Compatible strips
08.02.04 |
Fingolimod caps |
|
Neurology use only For Relapsing Remitting Multiple Multiple Sclerosis 02.03.02 |
Flecainide injection |
| 02.03.02 |
Flecainide tabs |
| 03.01.05 |
Flo-Tone MDI |
| 13.04 |
Flucinolone Acetonide 0.0025% Synalar 1 in 10 Dilution® |
Only on advice from specialist 13.04 |
Flucinolone Acetonide 0.00625% Synalar 1 in 4 Dilution® |
| 12.03.02 |
Fluconazole |
Only if topical ineffective/ inappropriate |
11.03.02 |
Fluconazole 0.2% preservative free |
This is a very specialist and restricted product prescribed only in specific circumstances. The fluconazole 0.2% drops product is an
24.01 |
Flucytosine injection |
Held at Ipswich Hospital Available as
20 |
Flucytosine 500mg tablets |
| 08.01.03 |
Fludarabine Phosphate Fludara® |
| 06.03.01 |
Fludrocortisone |
| 13.04 |
Fludroxycortide Haelan® tape |
For localized areas of lichen simplex chronicus/thickened skin where penetration of ordinary steroids may be an issue May help break itch/scratch cycle by covering the affected area Do not use with other topical steroids 15.01.07 |
Flumazenil injection |
| 12.01.01 |
Flumetasone 0.02% with Clioquinol 1% |
Expensive 11.99.99.99 |
Fluocinolone 190mcg/ml Iluvien® |
| 20 |
Fluorescein 20% 5ml amps |
| 11.10 |
Fluorescein Sodium |
Available as
11.04.01 |
Fluorometholone 0.1% FML® |
This is a mild steroid prescribed for a wide range of occular surface diseases. No preservative free formulation available. For a preservative free mild occular steroid, hydrocortisone or prednisolone 0.5% eye drops are available. 12.01.01 |
Fluoroquinolone |
Unlicensed product 08.01.03 |
Fluorouracil injection |
| 13.08.01 |
Fluorouracil Efudix® |
Traffic light information
04.03.03 |
Fluoxetine caps,dispersible tabs, liquid |
Avoid 10mg caps due to high cost Consider liquid (as oral solution) where doses of 10mg is needed. Please note: suger free version is expensive. Where possible choose the formulation that is not suger free. 04.02.01 |
Flupentixol tabs |
Flupentixol is a rarely prescribed and specialist treatment within Mental Health. It would not be initiated within the acute hospitals at Ipswich and Colchester but existing patients admitted to the organisation would have their treatment continued; and supplies procured accordingly if necessary. 04.02.02 |
Flupentixol Decanoate |
| 04.02.02 |
Fluphenazine Decanoate |
| 10.01.01 |
Flurbiprofen |
Ipswich Hospital Flurbiprofen is approved for use only to treat scleritis/episcleritis Colchester Hospital / NEECCG Flurbiprofen is considered a non-formulary medicine 11.11 |
Flurbiprofen Sodium 0.3% |
Single use eye drops Diclofenac 0.1% single use drops may be used if flurbiprofen is not available 08.03.04.02 |
Flutamide |
North East Essex CCG Flutamide prescribing responsibility may be taken over by the GP with agreement when clear guidance and monitoring information is provided. 12.02.01 |
Fluticasone furoate Avamys® |
Ipswich Hospital Fluticasone furoate nasal spray (Avamys) is non-formulary Colchester Hospital Fluticasone furoate nasal spray (Avamys) is considered a formulary medicine choice 12.02.01 |
Fluticasone Propionate Flixonase Nasule® |
Licensed for 16 and over 12.02.01 |
Fluticasone Propionate Nasofan® |
Available OTC for >18 years POM use- Licensed for 4 and over 03.02.02 |
Flutiform 125/5 Fluticasone propionate and formoterol |
Available as Licensed for adults and children >12 years
February 2021 - All strengths of the K-haler device are being discontinued from the UK market. The 125/5mcg device will be discontinued from April 2021.
03.02.02 |
Flutiform 250/10 Fluticasone propionate and formoterol |
Licensed for adults and children >12 years 03.02.02 |
Flutiform 50/5 Fluticasone propionate and formoterol |
Available as Licensed for adults and children >12 years
February 2021 - All strengths of the K-haler device are being discontinued from the UK market. The 50/5mcg device will be discontinued from August 2021. 09.01.02 |
Folic Acid tabs, liquid |
Check vitamin B12 levels in all people before starting folic acid 06.05.01 |
Follitropin Alfa endocrine |
| 06.05.01 |
Follitropin alfa infertility |
Available as
06.05.01 |
Follitropin Alfa and Beta endocrine |
| 24.01 |
Fomepizole 1g/ml x 1.5ml injection |
Held at Ipswich Hospital and not stocked at Colchester Hospital Available as
Administration details available on Toxbase 02.08.01 |
Fondaparinux |
Hospital only guidanceFor unstable angina, non ST-segment elevation myocardial infarction and ST-segment elevation myocardial infarction only 03.01.01.01 |
Formoterol Easyhaler® |
A LABA should only be used in asthmatic patients with an ICS. Adults and children >6 years 03.01.01.01 |
Formoterol Turbohaler® |
A LABA should only be used in asthmatic patients with an ICS. Adults and children >6 years
05.03.01 |
Fosamprenavir Telzir® |
| 04.06 |
Fosaprepitant Ivemend® |
| 24.01 |
Fosfomycin injection |
Held at Colchester Hospital Available as
03.02.02 |
Fostair 100/6 Beclometasone and formoterol |
Available as
Licensed for adults >18 years only. Moderate dose= 2 puffs BD 03.02.02 |
Fostair 100/6 Beclometasone and formoterol |
Available as
Licensed for adults >18 years only. Low dose= 1 puff BD 03.02.03 |
Fostair 100/6 Beclometasone and formoterol |
Available as
Licensed for adults >18 years only. 03.02.02 |
Fostair 200/6 Beclometasone and formoterol |
Available as
Licensed for adults >18 years only. 06.01.06 |
Freestyle Freedom Lite |
Omnipod Insulet pump handset/meter. Doubles as a meter and bolus advisor. Compatible test strips
06.01.06 |
Freestyle Libre |
IESCCG Only to be prescribed by GP following a recommendation by the diabetes team at Ipswich hospital Patients eligible for Freestyle Libre will be reviewed at 6 months by the specialist and then at 6-12 month intervals GPs are recommended to prescribe no more than 2 sensors (28 days) Please see links below for further information
NEECCG See link to policy below. 06.01.06 |
Freestyle Optium Neo meter |
Antenatal use only Compatible test strips
04.07.04.02 |
Fremanezumab Ajovy ® |
| 08.03.04.01 |
Fulvestrant Faslodex® |
| 20 |
Fumaric acid (Fumaderm) tablets |
Consultant dermatologists only for use in psoriasis 05.02 |
Fungizone Amphotericin |
Hospital only guidanceNot to be given IV Must be prescribed via brand For intravitreal use and line-locks See below for IHT medication safety newsletter 02.02.02 |
Furosemide tabs, liquid, injection |
Approximately 1mg bumetanide is equivalent to 40mg furosemide 11.03.01 |
Fusidic Acid 1% |
| 13.10.01.01 |
Fusidic acid 2% Fucidin® |
As resistance is increasing reserve topical antibiotics for very localised lesions Systematic review indicates topical and oral treatment produces similar results. Do not repeat topical treatment if treatment failure. 04.07.03 |
Gabapentin |
| 04.08.01 |
Gabapentin |
| 04.11 |
Galantamine XL |
Initiated and stabilised by secondary care 04.07.04.02 |
Galcanezumab Emgality |
| 04.07.04.02 |
Galcanezumab Emgality |
| 05.03.02.02 |
Ganciclovir |
| 11.03.03 |
Ganciclovir 0.15% ophthalmic gel Virgan® |
Second line ophthalmic antiviral therapy 08.01.03 |
Gemcitabine |
| 20 |
GEMTUZUMAB - OZOGAMICIN Injection 5 mg |
| 20 |
Gentamicin 0.1% cream |
Prophylaxis for exit site infections in CAPD pts allergic to mupirocin 11.03.01 |
Gentamicin 0.3% |
| 12.01.01 |
Gentisone HC Hydrocortisone Acetate 1% with Gentamicin 0.3% |
Expensive 08.01.05 |
Gilteritinib Xospata ® |
| 08.02.04 |
Glatiramer Acetate injection |
| 06.01.02.01 |
Gliclazide |
Ipswich Hospital Note-modified release preparation of gliclazide is not approved Gliclazide 30mg MR release is approximately equivalent to gliclazide 80mg standard release. Note: To ensure adequate distribution of gliclazide levels over 24 hours, when switching from modified release to standard release gliclazide, use the following equivalent dosing: 30mg once daily gliclazide MR= 40mg twice daily gliclazide standard release 60mg once daily gliclazide MR= 80mg twice daily gliclazide standard release Switching doses of gliclazide MR over 60mg daily to standard release gliclazide should be discussed with the Ipswich Hospital diabetes team
06.01.02.01 |
Gliclazide MR |
Ipswich Hospital Gliclazide m/r is a non-formulary medicine and a switch process is in place within the acute hospital to change patients to the normal release formulation Colchester Hospital Gliclazide m/r is considered a formulary medicine; it is unlikely that treatment would be initiated within the acute hospital but existing treatment would be continued if clinically appropriate. There is no formal switch process in place. NEECCG Considered a formulary medicine 06.01.02.01 |
Glimepiride |
| 06.01.04 |
Glucagon GlucaGen® HypoKit |
1 unit is equivalent to 1mg 06.01.01.03 |
GlucoRx Carepoint ® |
Primary care guidanceAvailable as
06.01.01.03 |
GlucoRx Carepoint Ultra ® |
Primary care guidanceAvailable as
Please note: GlucoRx Carepoint Ultra needle has a higher gauge in the 4mm length than the standard needle. As a result, patients may experience less discomfort when injecting. 06.01.06 |
GlucoRx Nexus Voice |
For patients with visual impairments Compatible test strips
06.01.06 |
GlucoRx Q meter |
Compatible strips
06.01.04 |
Glucose 20% 100ml infusion |
Hospital use only 06.01.04 |
Glucose 40% oral gel |
Padiatric inpatient use only 09.02.02.01 |
Glucose Intravenous |
| 06.01.04 |
Glucose power |
Hospital inpatient use only 01.06.02 |
Glycerol suppositories |
Avaiable OTC 20 |
Glycerol Injection |
Pain formulary only 02.06.01 |
Glyceryl Trinitrate |
| 02.06.01 |
Glyceryl Trinitrate |
| 02.06.01 |
Glyceryl Trinitrate |
| 02.06.01 |
Glyceryl Trinitrate |
| 01.07.04 |
Glyceryl Trinitrate 0.4% |
| 07.04.04 |
Glycine irrigation |
| 15.01.03 |
Glycopyrronium |
| 01.05.03 |
Golimumab |
| 10.01.03 |
Golimumab |
| 06.05.01 |
Gonadorelin injection |
| 20 |
Gonadorelin (relefact) 100mcg injection |
| 06.07.02 |
Goserelin |
Traffic light information
08.03.04.01 |
Goserelin Zoladex® |
| 08.03.04.02 |
Goserelin injection |
| 03.04.02 |
Grass pollen extract Grazax® |
Ipswich Hospital Grazax is considered a non-formulary medicine Colchester Hospital Grazax is considered a very restricted but a formulary medicine 02.05.03 |
Guanethidine Monosulphate Ismelin® |
Chronic Pain team at Ipswich hospital only 04.04 |
Guanfacine |
| 13.05.03.02 |
Guselkumab Tremfya |
Specialist use only for moderate to severe plaque psoriasis Homecare delivery for subcutaneous injection 14.04 |
Haemophilus influenzae type B |
| 14.04 |
Haemophilus influenzae type B Combined Vaccine Menitorix® |
| 03.01.05 |
Haleraid ® |
Available as
04.02.01 |
Haloperidol |
Traffic light information
IM and PO doses not interchangeable 04.02.02 |
Haloperidol decanoate |
| 02.08.01 |
Heparin sodium |
| 14.04 |
Hepatitis A vaccine |
| 14.04 |
Hepatitis A vaccine Single Component Avaxim® |
| 14.04 |
Hepatitis A vaccine Single Component Epaxal® |
| 14.04 |
Hepatitis A vaccine Single Component Havrix Monodose® |
| 14.04 |
Hepatitis A vaccine Single Component Vaqta® Paediatric |
| 14.04 |
Hepatitis A vaccine with Hepatitis B vaccine Twinrix® |
| 14.04 |
Hepatitis A vaccine with typhoid vaccine Hepatyrix® |
| 14.04 |
Hepatitis A vaccine with typhoid vaccine VIATIM® |
| 14.05.02 |
Hepatitis B immunoglobulin HBIG |
Only to be prescribed after consultation with an Ipswich Hospital microbiologist 14.04 |
Hepatitis B vaccine |
| 14.04 |
Hepatitis B vaccine Single Component Engerix B® |
| 14.04 |
Hepatitis B vaccine Single Component Fendrix® |
| 14.04 |
Hepatitis B vaccine Single Component HBvaxPRO® |
| 08.03.04.02 |
Histrelin injection |
| 06.01.01.02 |
Humalog® Mix |
Biphasic Insulin Lispro Available as:
06.05.01 |
Human Menopausal Gonadotrophins |
| 14.04 |
Human papilloma virus vaccine Gardasil® |
ESNEFT Hospital Only Prescribing for Laryngeal Papillomatosis in line wit hthe position statment from the British Laryngological Association (BLA). 14.04 |
Human papilloma virus vaccine Cervarix® |
| 14.04 |
Human papilloma virus vaccine Gardasil® |
| 14.04 |
Human papilloma virus vaccine (9-valent) Gardasil 9® |
| 06.01.01.02 |
Humulin® M3 |
Isophane Insulin human Available as:
06.01.01.01 |
Humulin® S |
Soluble insulin Available as:
10.01 |
Hyaluronic acid Durolane |
Restricted for use by Trauma and Orthopaedic Consultant (Pain Management) for patients with osteoarthritis in the knees: -who cannot tolerate analgesia, or for whom analgesia is contra-indicated -who do not experience clinical improvement but are unfit for surgery -who with to delay surgery
10.03.01 |
Hyaluronidase injection |
For use by ophthalmology and extravasation in paediatrics and neonates only 02.05.01 |
Hydralazine tabs |
| 02.05.01 |
Hydralazine injection |
| 06.03.02 |
Hydrocortisone |
Modified release tablets are not approved 12.03.01 |
Hydrocortisone Corlan® |
MHRA:Should not be used off-label for adrenal insufficiency in children due to serious risks Available OTC 13.04 |
Hydrocortisone 0.5% and 1% cream and ointment |
Can be bought OTC for patients ≥10yrs for the following
Cannot be used for the face if purchacing OTC If treating the body use a moderate steroid 1st line. 06.03.02 |
Hydrocortisone sodium phosphate Efcortesol® injection |
Already in solution 06.03.02 |
Hydrocortisone sodium succinate Solu-Cortef® injection |
Requires reconstitution 13.04.04 |
Hydrocortisone 1% with Clotrimazole 1% Canesten HC cream ® |
Can be bought OTC 13.04.04 |
Hydrocortisone 1% with Miconazole Nitrate 2% Daktacort® cream/ointment |
Can be bought OTC For seborrheic dermatitis 10.01.02.02 |
Hydrocortisone acetate |
| 13.04.04 |
Hydrocortisone Acetate 1% with Fusidic Acid 2% Fucidin H® cream |
Can be bought OTC 01.05.02 |
Hydrocortisone foam enema Colifoam® |
| 06.03.02 |
Hydrocortisone MR Plenadren |
Ipswich Hospital - Used only following an individual funding request by Ipswich Hospital endocrinologist, approved by CCG. Colchester Hospital - product is completely Non-Formulary 11.04.01 |
Hydrocortisone sodium phosphate eye drops 3.35mg/ml Softacort |
Ipswich Hospital Advice from Ophthalmologist: Softacort is a mild steroid with the lowest published rate of secondary raised intraoccular pressure, which is preservative free. Other mild steroid options include prednisolone 0.5% and FML eye drops. FML is only available as a preserved eye drop and prednisolone 0.5% is available as both preserved and preservative free eye drops 12.03.04 |
Hydrogen Peroxide 3% |
For post-tonsillectomy haemorrhage 12.03.04 |
Hydrogen Peroxide 6% |
Acute ulcerative gingivitis 09.01.02 |
Hydroxocobalamin Vitamin B12 |
| 08.01.05 |
Hydroxycarbamide |
Traffic light information
10.01.03 |
Hydroxychloroquine |
| 11.08.01 |
Hydroxypropyl Guar Systane® |
Ipswich Hospital The Systane range of products are non-formulary medicines Colchester Hospital & NEECCG The Systane range of products (Systane, Systane Balance and Systane Ultra) are considered formulary medicine choices. Systane Ultra is to be initiated by a specilaist opthalmic practitioner.
03.04.01 |
Hydroxyzine |
MHRA:Risk of QT interval prolongation and Torsade de Pointes 01.02 |
Hyoscine Butylbromide |
MHRA: Serious adverse effects in patients with underlying cardiac disease Available as
04.06 |
Hyoscine Hydrobromide |
| 15.01.03 |
Hyoscine Hydrobromide |
Hospital only for anaesthesia 11.08.01 |
Hypromellose 0.3% |
Can be bought OTC Available as
Ipswich Hospital Hypromellose drops are considered a formulary medicines choice Colchester Hospital & NEECCG Hypromellose drops are considered a non-formulary medicine 06.06.02 |
Ibandronic Acid 50mg tablets |
Specialist initiation Reduction of bone damage in bone metastases in breast cancer 06.06.02 |
Ibandronic Acid injection |
Ipswich Hospital Ibandronic acid injection is a formulary medicine - for postmenopausal osteoporosis for patients unable to take/intolerant to oral medicines Colchester Hospital Ibandronate acid injection is considered non-formulary 08.01.05 |
Ibrutinib caps |
| 07.01.01.01 |
Ibuprofen injection |
| 10.01.01 |
Ibuprofen |
MHRA:High-dose ibuprofen (≥2400mg/day):small increase in cardiovascular risk Can be bought OTC 10.03.02 |
Ibuprofen gel 5% |
| 08.01.02 |
Idarubicin caps, injection |
| 02.08 |
Idarucizumab |
Reversal agent for Dabigatran 08.01.05 |
Idelalisib tabs |
| 08.01.01 |
Ifosfamide injection |
| 20 |
Iloprost |
Available as
02.06.04 |
Iloprost injection |
08.01.05 |
Imatinib tabs, caps |
| 04.03.01 |
Imipramine tabs, liquid |
Liquid is high cost Maybe used as an alternative to trimipramine For neuropathic pain if intolerant to amitriptyline 04.07.03 |
Imiprimine |
Unlicensed indication Only if intolerant to amitriptyline 13.07 |
Imiquimod 5% Aldara® cream |
| 13.08.01 |
Imiquimod 5% Aldara® cream |
| 13.02.01 |
Imuderm ® |
Can be bought OTC Equivalent to Balnuem® cream 14.04 |
Inactivated Influenza Vaccine (Split Virion) |
| 14.04 |
Inactivated Influenza Vaccine (Surface Antigen) |
| 02.02.01 |
Indapamide (Immediate Release) |
Indapamide Modified Release tablets are considered non-formulary. 11.11 |
Indermil |
Tissue adhesive 05.03.01 |
Indinavir Crixivan® |
| 11.10 |
Indocyanine green 5mg/ml injection |
| 07.01.01.01 |
Indometacin injection |
| 10.01.01 |
Indometacin |
Hospital use only for acute gout
07.04.01 |
Indoramin Doralese® |
Restricted use - indoramin is unlikely to be initiated within the acute Trust for urinary retention but existing therapy would be continued on if appropriate
14.04 |
Infanrix IPV ® |
| 14.04 |
Infanrix-IPV+Hib ® |
| 01.01.02 |
Infant Gaviscon ® |
Paediatric patients only 01.05.03 |
Infliximab Inflectra |
Hospital only guidancePrescribing Infliximab
Should patients experience unexpected side effects, lack of tolerance or a symptom flare while using the biosimilar, the originator product i.e Remicade® should be used 10.01.03 |
Infliximab Inflectra® |
Prescribing infliximab at Ipswich Hospital
Prescribing infliximab at Colchester Hospital
13.05.03.02 |
Infliximab Inflectra® |
Hospital only guidancePrescribing Infliximab
Should patients experience unexpected side effects, lack of tolerance or a symptom flare while using the biosimilar, the originator product i.e Remicade® should be used 14.04 |
Influenza vaccine |
| 13.08.01 |
Ingenol mebutate Picato® |
MHRA: Suspension of the license due to risk of skin malignancy 08.01.05 |
Inotuzumab ozogamicin Besponsa® |
| 06.01.01.02 |
Insulatard® Isophane Insulin |
Basal Insulin-First Line Available as:
06.01.01.01 |
Insulin Insuman® Rapid |
Ipswich Hospital Soluble insulin (Insuman) is considered a non-formulary medicine Colchester Hospital Soluble insulin (Insuman) is considered a formulary medicine; albeit with very limited use in practice. Treatment would not usually be initiated within the acute hospital
NEECCG Considered a formulary medicine 06.01.01.02 |
Insulin degludec Tresiba® |
Ipswich Hospital Insulin degludec (Tresiba) 200units/ml is a non-formulary medicine Colchester Hospital Insulin degludec (Tresiba) 200units/ml is a formulary medicine - but very restricted use; only for patients requiring high doses of insulin therapy to decrease injection volume load 06.01.01.01 |
Insulin Glulisine Apidra® |
Ipswich Hospital Insulin glulisine is a non-formulary medicine Colchester Hospital Insulin glulisine is considered a formulary medicine, although it is not commonly used in practice and treatment must be initiated by the hospital's Diabetes Team
NEECCG Considered a formulary medicine
06.01.01.01 |
Insulin Lispro 200 units/ml Humalog® |
Ipswich Hospital Insulin Lispro 200units/ml is considered a non-formulary medicine Colchester Hospital Insulin Lispro 200units/ml is considered a formulary medicine, but with very restricted usage. Only for patients requiring high doses of insulin therapy; to decrease injection volume load NEECCG Considered a formulary medicine 08.02.04 |
Interferon Alfa IntronA |
| 08.02.04 |
Interferon Alfa Roferon-A® |
| 08.02.04 |
Interferon Alfa Viraferon® |
| 08.02.04 |
Interferon Beta Avonex® |
Only approved for use for patients conforming to national MS trial criteria 08.02.04 |
Interferon Beta Rebif® |
Only approved for use for patients conforming to national MS trial criteria 07.03.02.03 |
Intra-uterine Progestogen Only System Jaydess® |
Ipswich Hospital Jaydess is a non-formulary medicine Colchester Hospital / NEECCG Jaydess is considered a formulary medicines choice (noting that the Kyleena formulation has also recently been approved for use also) 20 |
IOPANOIC ACID Tablets 500 mg |
For endocrinology team use only 08.01.05 |
Ipilimumab injection |
| 03.01.02 |
Ipratropium inhaler |
| 03.01.02 |
Ipratropium nebules |
Only if patient unable to use inhalers / patients with severe disease. 12.02.02 |
Ipratropium Bromide |
| 02.05.05.02 |
Irbesartan |
| 08.01.05 |
Irinotecan Hydrochloride injection |
| 09.01.01.01 |
Iron and Folic Acid Pregaday® |
Antenatal clinics only 09.01.01.02 |
Iron Dextran CosmoFer® |
Hospital only guidanceIron Dextran (Cosmofer) is the iron infusion of choice for hospitalised patients for whom discharge from hospital is not imminent. It is administered as an infusion over approximately 4-6hours and required initial careful monitoring for sensitivity reactions.Dose calculatorClick here to open up Cosmofer calculator 09.01.01.02 |
Iron Sucrose Venofer® |
| 08.02.03 |
Isatuximab injection |
| 15.01.02 |
Isoflurane |
| 13.02.01 |
Isomol ® |
Can be bought OTC
Equivalent to Doublebase® Can be used as a soap substitute
As of March 2020 Isomol gel was renamed Epimax Isomol gel. 20 |
Isoniazid 50mg / 5ml oral solution |
| 02.07.01 |
Isoprenaline |
02.06.01 |
Isosorbide Dinitrate |
Specialist cardiology use only 02.06.01 |
Isosorbide Mononitrate MR tablets, MR capsules, tablets |
XL preparations are for once daily administration. Note: 60mg XL tablets can be halved to make a 30mg XL once daily dose 13.06.02 |
Isotretinoin |
|
MHRA:Risk of serious skin reactions MHRA:Risk of psychiatric disorders MHRA:Rare reports of erectile dysfunction and decreased libido Hospital only guidancePregnancy Prevention Programme (PPP)All prescriptions for females of childbearing age should be endorsed with either "On PPP" or "Not PPP" On PPP
Not PPP
13.06.01 |
Isotretinoin with antibacterial Isotrexin® |
| 01.06.01 |
Ispaghula Husk |
Adequate fluid intake must be maintained to avoid intestinal obstruction. Should not be taken before going to bed 02.06.03 |
Ivabradine |
| 13.10.04 |
Ivermectin tablets |
See link below for prescribing advice 13.06.03 |
Ivermectin cream Soolantra® |
| 08.01.05 |
Ixazomib Ninlaro® |
| 13.05.03.02 |
Ixekizumab |
| 13.08.02 |
Keromask ® |
| 15.01.01 |
Ketamine injection |
| 13.09 |
Ketoconazole Nizoral® |
Can be bought OTC 10.03.02 |
Ketoprofen 2.5% Oruvail ®, Powergel® |
Ipswich Hospital Ketoprofen 2.5% gel is non-formulary Colchester Hospital / NEECCG Ketoprofen 2.5% gel is considered a formulary medicine choice. 11.11 |
Ketorolac 0.5% eye drops |
| 11.04.02 |
Ketotifen 0.25mg/ml Ketofall |
Approved for Ipswich Hospital and Colchester Hospital Preferred choice of preservative-free mast cell stabiliser antihistamine eye drops 06.01.06 |
KEYA Smart Blood glucose and ketone meter |
Hospital recommendation only Compatible test strips
01.06.05 |
Klean-Prep ® |
For use in renal failure (eGFR< 45ml/min) 13.14 |
Kligman’s formula |
| 06.04.01.01 |
Kliofem estradiol 2mg + norethisterone acetate 1mg |
| 06.04.01.01 |
Kliovance estradiol 1mg + norethisterone acetate 500mcg |
| 02.04 |
Labetalol |
Used for hypertension in pregnancy 04.08.01 |
Lacosamide |
| 01.06.04 |
Lactulose |
Available OTC 05.03.01 |
Lamivudine Epivir® |
Indicated for HIV infection in combination with other antiretroviral drugs. Also indicated for chronic hepatitis B infection. 05.03.03.01 |
Lamivudine Zeffix® |
| 05.03.03.01 |
Lamivudine Zeffix |
Indicated for chronic hepatitis B infection. Also indicated for HIV infection in combination with other antiretroviral drugs. 04.08.01 |
Lamotrigine |
Traffic light information
03.04.03 |
Lanadelumab |
For preventing recurrent attacks of hereditary angioedema 06.01.01.03 |
Lancets |
Primary care guidanceOnly prescribe lancets which cost less than £3 per 100 lancets See below for formulary choices Options include
08.03.04.03 |
Lanreotide Somatuline Autogel® |
Traffic light information
01.03.05 |
Lansoprazole caps |
Lansoprazole is the Proton-Pump-Inhibitor of choice for patients on clopidogrel treatment. 01.03.05 |
Lansoprazole orodispersible and Zoton® |
Joint guidanceOrodispersible tabletsReserved for patients with swallowing difficulties Paediatric use- see below for IHT prescribing guidance 09.05.02.02 |
Lanthanum Fosrenol ® |
Hyperphosphataemia in established renal failure on dialysis 08.01.05 |
Lapatinib |
| 08.01 |
Larotrectinib VITRAKVI ® |
| 11.06 |
Latanoprost 50mcg/ml eye drops |
MHRA:Increased reporting of eye irritation since reformulation Available as
11.06 |
Latanoprost and Timolol |
Available as 0.005% / 0.5% 13.02.02 |
LBF Barrier film applicators |
Available as
For use around wounds 13.02.02 |
LBF Barrier cream 2g sachet |
For use on intact but vulnerable skin 13.02.02 |
LBF Barrier film spray 30ml |
For use on broken skin 05.03.03.02 |
Ledipasvir and Sofosbuvir Harvoni® |
| 10.01.03 |
Leflunomide |
| 08.02.04 |
Lenalidomide caps |
| 08.01.05 |
Lenvatinib Lenvima® |
| 02.06.02 |
Lercanidipine |
| 08.03.04.01 |
Letrozole |
| 08.03.04.01 |
Letrozole |
ESNEFT: Letrozole for ovulation induction for subfertility. 06.07.02 |
Leuprorelin |
First line for gynaecology e.g. endometriosis, endometrial thinning 08.03.04.02 |
Leuprorelin Acetate injeciton |
| 20 |
LEVAMISOLE Tablets 50 mg |
| 04.08.01 |
Levetiracetam tabs, liquid |
| 04.08.01 |
Levetiracetam injection |
| 15.02 |
Levobupivacaine |
May be less cardiotoxic than (racemic) bupivacaine. Only to be used in higher risk procedures e.g. where >20ml 0.5% bupivacaine would be required. 11.03.01 |
Levofloxacin 0.5% |
Available as
04.06 |
Levomepromazine tabs, injection |
Palliative care use 07.03.05 |
Levonorgestrel 1.5mg |
MHRA:Advice on interactions with hepatic enzyme inducers and contraceptive efficacy Can be used up to 72 hours after unprotected intercourse 06.02.01 |
Levothyroxine |
Note: levothyroxine liquid is very expensive compard to oral tablet therapy and so must only be prescribed in justifiable circumstances 02.03.02 |
Lidocaine |
| 15.02 |
Lidocaine injection |
| 15.02 |
Lidocaine 4% topical cream |
| 11.11 |
Lidocaine 4% Fluorescein 0.25% |
Single use eye dops 15.02 |
Lidocaine 4%, adrenaline 1:1000, tetracaine 0.5% LAT |
Single use only
Use within 24 hours of opening
For use in the Paediatric Emergency Department (Ipswich Hospital) as a local anaesthetic for wounds less than 5cm requiring suturing, in children over 1 year |
15.02 |
Lidocaine 5% and Phenylephrine 0.5% |
| 12.03.01 |
Lidocaine and Hydrocortisone mouthwash |
Hospital use only Unlicensed special (made in the pharmacy manufacturing unit at IHT) 04.07.03 |
Lidocaine plasters |
Green for its licensed indication ONLY: Post Herpatic Neuralgia For any other indication this is considered NON-FORMULARY 15.02 |
Lidocaine with Adrenaline injection |
| 15.02 |
Lidocaine2% with Chlorhexidine 0.25% Instillagel® |
| 01.06.07 |
Linaclotide Constella® |
Joint guidancePrescribing and MonitoringFor the symptomatic treatment of moderate to severe irritable bowel syndrome with constipation (IBS-C) in adults where the patient’s symptoms have failed to resolve with:
GP to review after 4 weeks and if they have not experienced improvement in their symptoms they should be re-examined and the benefit and risks of continuing treatment reconsidered. 06.01.02.03 |
Linagliptin |
Reserved for patients with fluctuating renal function 06.02.01 |
Liothyronine injection |
Very speciailist use - only utilised within the Critical Care setting as part of agreed organ donor optimisation pathways
06.02.01 |
Liothyronine tabs |
Joint guidanceNote: Armour thyroid must never be prescribed Liothyronine is classed as medicine of low clinical value by NHSEInitiation
Liothyronine is only to be used following a successful 3 month trial by an endocrinology consultant. Please see below for further guidance
Existing patients
Existing patients should be screened by endocrinology to determine the suitability of continuing liothyronine. GP should fill out the questionnaire( see below) and send it to the endocrine team for review who will advise the GP of the next steps. 13.02.01 |
Liquid and White Soft Paraffin Ointment (50:50) |
11.08.01 |
Liquid Paraffin eye ointment |
Can be bought OTC Available as
11.08.01 |
Liquid Paraffin eye ointment with retinol palmitate |
HYLO Night ® eye ointment (preservative free) 04.04 |
Lisdexamfetamine caps |
| 02.05.05.01 |
Lisinopril |
| 04.02.03 |
Lithium Carbonate tabs |
Must be maintained on same brand 04.02.03 |
Lithium Citrate liquid |
Must be maintained on same brand Lithium carbonate 200mg is approximately equivalent to lithium citrate 509mg Most lithium tablets are modified-release therefore when being given as a liquid the total daily dose will need to be given in divided doses. 06.01.02.03 |
Lixisenatide |
Ipswich Hospital/IESCCG Lixisenatide is considered non-formulary Colchester Hospital/NEECCG Lixisenatide is considered a formulary medicine 04.03.01 |
Lofepramine tabs, liquid |
Lofepramine is a rarely prescribed and specialist treatment. It would not be initiated within the acute hospitals at Ipswich and Colchester but existing patients admitted to the organisation would have their treatment continued; and supplies procured accordingly if necessary. 08.01.01 |
Lomustine caps |
check if this is ULM as well 01.04.02 |
Loperamide |
MHRA:Serious cardiac adverse reactions with high doses of loperamide associated with abuse or misuse Available OTC Doses of upto 16mg QDS can be used for stoma patients 05.03.01 |
Lopinavir and Ritonavir Kaletra® |
| 03.04.01 |
Loratadine |
Available OTC 04.01.01 |
Lorazepam tabs |
Tablets can be used sublingually 04.08.02 |
Lorazepam |
For status epilepticus, rapid tranquilisation and sedation 15.01.04.01 |
Lorazepam |
| 08.01 |
Lorlatinib Lorviqua |
| 02.05.05.02 |
Losartan |
| 11.11 |
Loteprednol 0.5% eye drops |
| 03.01.05 |
Low range peak flow meter Pocket peak® |
Specify as "low range peak flow meter" on prescription 06.02.02 |
Lugols |
| 09.01.04 |
Lusutrombopag tablets Mulpleo ® |
MHRA:Reports of interference with bilirubin and creatinine test results 13.06.02 |
Lymecycline Tetralysal®300 |
| 13.06.03 |
Lymecycline |
Unlicensed indication Use only if compliance is a problem 01.06.04 |
Macrogol oral powder |
Available OTC 09.05.01.03 |
Magnesium Glycerophosphate NeoMag ® |
4mmol chewable tablets 20 |
Magnesium glycerophosphate liquid |
| 01.06.04 |
Magnesium Hydroxide Mixture BP |
Available OTC 09.05.01.03 |
Magnesium Sulphate injection |
|
Available as
01.01.01 |
Magnesium Trisilicate |
Available OTC 02.02.05 |
Mannitol |
Hospital ITU only For cerebral oedema 03.07 |
Mannitol inhalation Bronchitol ® |
Cystic Fibrosis Only 05.03.01 |
Maraviroc Celsentri® |
| 14.04 |
Measles, Mumps and Rubella Vaccine, Live (MMR) |
| 01.02 |
Mebeverine tablets |
Available OTC The modified-release MR preparation is not approved for prescribing and is considered Non-Formulary. 06.04.01.02 |
Medroxyprogesterone Acetate Provera® |
| 07.03.02.02 |
Medroxyprogesterone Acetate Depo-Provera® |
repeated every 12 weeks 07.03.02.02 |
Medroxyprogesterone acetate Sayana Press® |
Ipswich Hospital Sayana Press is a non-formulary medicine Colchester Hospital Syana Press is considered a formulary medicine choice 08.03.02 |
Medroxyprogesterone Acetate Provera® |
North East Essex CCG Medroxyprogesterone (Provera) is considered a medicine that requires specialist initiation for oncology related indications. 10.01.01 |
Mefenamic Acid |
For menorrhagia 08.03.02 |
Megestrol Acetate tabs, suspension |
| 04.01.01 |
Melatonin |
Traffic light information
Available as
10.01.01 |
Meloxicam |
Ipswich Hospital Meloxicam is considered a formulary medicine Colchester Hospital / NEECCG Meloxicam is considered a non-formulary medicine 08.01.01 |
Melphalan tabs |
| 04.11 |
Memantine |
Initiated and stabilised by secondary care At Ipswich Hospital, memantine liquid is non-formulary. Orodispersible tablets are formulary and are used as an alternative to liquid. 09.06.06 |
Menadiol Sodium Phosphate tabs |
Water soluble vitamin K preparation. Preparation of choice for patients with biliary obstruction or hepatic disease. 14.04 |
Meningococcal A, C, W135, and Y conjugate vaccine Menveo® |
| 14.04 |
Meningococcal group B Vaccine Bexsero® |
| 14.04 |
Meningococcal group C conjugate vaccine |
| 14.04 |
Meningococcal group C conjugate vaccine Menjigate Kit® |
| 14.04 |
Meningococcal polysaccharide A, C, W135 and Y vaccine ACWY Vax® |
| 06.05.01 |
Menotrophin injection |
| 06.05.01 |
Menotrophin injection |
Fertility monitoring unit only Avaiable as
13.03 |
Menthol 1% in aqueous cream |
For pruritus in pregnancy if standard emollients do not work 13.03 |
Menthol 5% in aqueous cream |
For use if Menthol 1% in aqueous cream fails 20 |
Mepacrine 100mg |
| 15.02 |
Mepivacaine 3% injection |
| 04.07.02 |
Meptazinol |
200mg meptazinol is equivalent to approximately to 8mg morphine 01.05.03 |
Mercaptopurine |
Treatment of inflammatory bowel disease 20 |
Mercaptopurine 10mg tablets |
| 01.05.01 |
Mesalazine |
Joint guidanceMust be prescribed by brand Different brands and formulations of mesalazine are not interchangeable If prescribed generically clarify preparation required with the prescriber If patients are prescribed non-formulary brands e.g patients who have moved recently or admitted into hospital- please discuss with gastroenterology before changing brand The following mesalazine preparations are considered formulary:
08.01 |
Mesna tabs,liquid,injection |
| 02.07.02 |
Metaraminol |
| 20 |
Metaraminol 10mg in 1ml injection |
| 06.01.02.02 |
Metformin |
Available as
06.01.02.02 |
Metformin modified release |
Prescribe only if intollerent to stardard release metformin 04.07.02 |
Methadone |
At Colchester hospital/North East Essex CCG, the use of methadone within analgesic practice is limited to specialist use within Palliative Care. 04.10.03 |
Methadone 1mg/ml |
Can be prescribed for pallative care
01.05.03 |
Methotrexate |
Hospital only guidanceInpatient drug charts prescribing advice
Charts must be validated by a pharmacist before a supply can be made Note: STP-wide Shared Care Guideline are in place relating to the use of methotrexate within Inflammatory Bowel Disease patients. These guidelines are available via the respective Clinical Commissioning Group websites.
Primary care guidanceRisk of overdosePlease check records/clinic letters to ensure the patient is not receiving any injectable methotrexate in secondary care 01.05.03 |
Methotrexate injection |
IESCCG/Ipswich Hospital Methotrexate injection is hospital only NEECCG/Colchester Hospital Methotrexate injection is shared care Primary care guidance (IESCCG)SafetyPlease ensure medical records are up to date and methotrexate is noted as a regular medicine. This will ensure drugs that significantly interact e.g. trimethoprim are not prescribed. 07.05 |
Methotrexate gynaecology |
| 10.01.03 |
Methotrexate |
Hospital only guidanceInpatient drug charts prescribing advice
Charts must be validated by a pharmacist before a supply can be made See below for IHT newsletters
Primary care guidanceRisk of overdosePlease check records/clinic letters to ensure patient is not receiving any injectable methotrexate in secondary care 10.01.03 |
Methotrexate injection |
Ipswich Hospital The use of methotrexate syringes within rheumatology is considered "hospital-only" Colchester Hospital / NEECCG The use of methotrexate syringes within rheumatology and other disorders is allowable within Primary Care under agreed Shared Care Guidance. 11.99.99.99 |
Methotrexate |
Injection prepared for intravitreal use 13.05.03 |
Methotrexate |
Hospital only guidanceInpatient drug charts prescribing advice
Charts must be validated by a pharmacist before a supply can be made See below for IHT newsletters
Primary care guidanceRisk of overdosePlease check records/clinic letters to ensure patient is not receiving any injectable methotrexate in secondary care 04.07 |
Methoxyflurane Penthrox® |
For use by Suffolk Ambulance Rescue Service (SARS) only 13.08.01 |
Methyl-5-Aminolevulinate Metvix® |
This product is for use at Ipswich Hospital by the Dermatology team only. It is not supplied to patients for use at home. 02.05.02 |
Methyldopa tabs |
For hypertension when other agents have failed or not suitable 01.06.06 |
Methylnaltrexone Relistor® |
At both Ipswich and Colchester Hospital sites, for specific use within the Hospice environments and Palliative care patients only 04.04 |
Methylphenidate Hydrochloride MR tabs |
Must be prescribed by brand Must be maintained on same brand 06.03.02 |
Methylprednisolone tabs |
For use in MS relapse 10.01.02.02 |
Methylprednisolone Acetate Depo-Medrone® |
| 04.06 |
Metoclopramide |
MHRA:Risk of neurological adverse effects Not licensed for people under 20 years old and is known to cause oculogyric crisis, especially in young adults Should not be prescribed for longer than 5 days 02.02.01 |
Metolazone |
02.04 |
Metoprolol |
| 13.06.03 |
Metronidazole 0.75% Rozex® gel or cream |
| 06.07.03 |
Metyrapone Metopirone® |
Note: this treatment is very expensive and when appropriate, must only be initiated by a Consultant specialist Ipswich Hospital Metyrapone is considered a formulary medicine Colchester Hospital Metyrapone is considered a non-formulary medicine 12.03.02 |
Miconazole Daktarin® |
MHRA:Significant interaction with warfarin Available OTC 13.10.02 |
Miconazole 2% |
Can be bought OTC 04.08.02 |
Midazolam buccal solution |
| 15.01.04.01 |
Midazolam 1mg/ml pre-med |
Caution-check strength of preparation carefully. High strength midazolam injection 10mg/2ml is available for palliative care use. 20 |
MIDAZOLAM buccal |
| 02.07.02 |
Midodrine |
| 08.01.05 |
Midostaurin Rydapt |
| 07.01.02 |
Mifepristone tabs |
For termination of pregnancy
07.04.02 |
Mirabegron Betmiga® |
MHRA:Risk of severe hypertension and associated cerebrovascular and cardiac events For use in overactive bladder syndrome when antimuscarinics are clinically ineffective, contraindicated or have unacceptable side effects. 07.03.02.03 |
Mirena® Intra-uterine Progestogen Only System |
MHRA:Levonorgestrel-releasing intrauterine systems: prescribe by brand name 04.03.04 |
Mirtazapine tab, orodispersible tabs |
| 07.01.01 |
Misoprostol tabs |
Hospital only guidanceGynaecology use onlyGiven orally or vaginally for the induction of labour (Unlicensed indication). Can be used sublingually/rectally in postpartum haemorrhage when oxytocin, ergometrine and carboprost are not available or are inappropriate 08.01.02 |
Mitomycin |
| 11.11 |
Mitomycin C |
Unlicensed special Available as
08.01.02 |
Mitoxantrone (Mitozantrone) |
| 15.01.05 |
Mivacurium injection |
| 04.03.02 |
Moclobemide tabs |
Moclobemide is a rarely prescribed and specialist treatment within Mental Health. It would not be initiated within the acute hospitals at Ipswich and Colchester but existing patients admitted to the organisation would have their treatment continued; and supplies procured accordingly if necessary. 04.04 |
Modafinil tabs |
Letter to Healthcare professional: Potential risk of congenital malformations during pregnancy 12.02.01 |
Mometasone Furoate |
Available OTC 13.04 |
Mometasone Furoate 0.1% cream, ointment and scalp lotion |
Use ONCE daily 03.03.02 |
Montelukast Singulair® |
MHRA:reminder of the risk of neuropsychiatric reactions Adults – see asthma pathway Children over 5 years: see asthma pathway Children under 5 years: see asthma pathway Child 13-18 years:see asthma pathway 04.07.02 |
Morphine sulphate MR caps |
Prescribe by brand
04.07.02 |
Morphine sulphate intrathecal injection |
| 04.07.02 |
Morphine sulphate injection |
| 04.07.02 |
Morphine sulphate liquid |
Available as
04.07.02 |
Morphine sulphate suppositories |
Ipswich Hospital and Colchester Hospital Morphine suppositories are non-formulary and are not utilised within the acute hospital 15.01.04.03 |
Morphine sulphate Epidural injection |
| 10.03.02 |
Movelat Topical gel / cream |
North East Essex CCG Movelat is a Non-Formulary medicine. It is available OTC. 02.05.02 |
Moxonidine |
For hypertension when other agents have failed or not suitable 09.06.07 |
Multivitamin preparations Abidec® |
| 09.06.07 |
Multivitamin preparations Dalivit® |
| 09.06.07 |
Multivitamins |
Can be bought OTC 13.10.01.01 |
Mupirocin Bactroban® cream, ointment |
Reserved for treating MSRA 10.01.03 |
Mycophenolate Oral |
| 10.01.03 |
Mycophenolate |
| 13.05.03 |
Mycophenolate |
MHRA:Updated contraception advice for male patients Severe refractory eczema [unlicensed indication] 08.02.01 |
Mycophenolate Mofetil caps, tabs |
MHRA:Updated contraception advice for male patients Traffic light information
08.02.01 |
Mycophenolate Sodium tabs |
MHRA:Updated contraception advice for male patients Also known as Mycophenoloic Acid Mycophenolic acid 720 mg is approximately equivalent to mycophenolate mofetil 1g but avoid unnecessary switching because of pharmacokinetic differences. 20 |
Mydricaine No. 2 injection |
| 06.05.01 |
Nafarelin nasal spray |
Fertility monitoring unit only |
02.06.04 |
Naftidrofuryl |
| 04.10.01 |
Nalmefene |
Prescribed by Turning Point 01.06.06 |
Naloxegol |
At both Ipswich and Colchester hospitals, strictly as a possible treatment for opioid-induced constipation in adults whose constipation has not adequately responded to laxatives; in accordance with NICE TA345. Specialist/Consultant initiation only. 15.01.07 |
Naloxone injection |
PSA: Support to minimise the risk of distress and death from inappropriate doses of naloxone 04.10.03 |
Naltrexone Nalorex® |
| 10.01.01 |
Naproxen |
| 12.02.03 |
Naseptin Chlorhexidine Hydrochloride 0.1%, Neomycin Suphate 0.5% |
For eradication and prevention of nasal carriage of staphylococci Avoid in the following groups due to arachis oil content
11.03.02 |
Natamycin 5% |
This is a very specialist and restricted product prescribed only in specific circumstances. The natamycin 5% drops product is an A small supply is held in stock at Ipswich hospital on behalf of both sites.
24.01 |
Natamycin 5% eye drops |
Held at Ipswich Hospital NB – these can be sight-saving in certain types of fungal eye infections, so will need to be couriered ASAP 06.01.02.03 |
Nateglinide |
| 02.04 |
Nebivolol |
Cardiology initiation only 08.01.03 |
Nelarabine |
| 05.03.01 |
Nelfinavir Viracept® |
| 11.04.02 |
Neodocromil 2% Rapitil® |
| 10.02.01 |
Neostigmine injection |
| 10.02.01 |
Neostigmine tablets |
| 15.01.06 |
Neostigmine metisulfate injection |
| 15.01.06 |
Neostigmine metisulfate with Glycopyrronium injection |
| 11.11 |
Nepafenac |
Only for postoperative macular oedema associated with cataract surgery in diabetic patients Available as
05.03.01 |
Nevirapine Viramune® |
| 02.06.03 |
Nicorandil |
| 04.10.02 |
Nicotine replacement therapy |
| 02.06.02 |
Nifedipine tablets and modified release preparations |
Non-MR capsules not recommended for hypertension 07.01.01 |
Nifedipine gynaecology |
Unlicensed use Used as tocolytic to postpone premature labour 08.01.05 |
Nilotinib |
| 02.06.02 |
Nimodipine tablets, injection |
Therapy strictly reserved for the treatment of subarrachnoid haemorrhage - hospital only supply 08.01.05 |
Niraparib caps |
| 08.02.04 |
Nivolumab |
| 07.03.01 |
nomegestrol acetate and beta estradiol Zoely® |
Ipswich Hospital Nomegestrol acetate and beta estradiol (Zoely) is strictly considered a non-formulary medicine (classifed as "Double Red" - no prescribing allowed at all) Colchester Hospital Nomegestrol acetate and beta estradiol (Zoely) is considered a restricted and quite specialist formulary medicine 02.07.02 |
Noradrenaline / Norepinephrine |
Hospital ITU or anaesthesia only 06.04.01.02 |
Norethisterone |
| 07.03.02.01 |
Norethisterone 350mcg |
| 07.03.02.02 |
Norethisterone enantate Noristerat® |
repeated every 8 weeks 14.05.01 |
Normal Immunoglobulin Gammaplex® |
14.05.01 |
Normal immunoglobulin for Intravenous use Privigen |
14.05.01 |
Normal immunoglobulin for Subcutaneous use |
06.01.01.01 |
NovoRapid® Insulin Aspart |
Rapid acting insulin anologue- First line Available as:
A2.05.02 |
Nutilis Clear Nutilis® |
Available as: 175g tin with a 1.25g scoop - first line choice. Also available as 1.25g sachets - do not prescribe as not cost-effective. 12.03.02 |
Nystatin |
| 08.02.03 |
Obinutuzumab injection |
| 08.02.04 |
Ocrelizumab Injection |
| 11.99.99.99 |
Ocriplasmin 0.5mg/0.2ml Jetrea® |
| 12.02.03 |
Octenidine Nasal gel |
Use in the following cases:
AND
08.03.04.03 |
Octreotide Sandostatin® |
Traffic light information
08.03.04.03 |
Octreotide Sandostatin Lar® |
Colchester Hospital / NEECCG Traffic light information
06.04.01.01 |
Oestrogen only HRT patch Estradot, Evorel |
| 06.04.01.01 |
Oestrogen only HRT tablet Elleste-Solo, Premarin |
| 06.04.01.01 |
Oestrogens for HRT FemSeven® Sequi |
| 07.02.01 |
Oestrogens, Topical Estring® |
Ipswich Hospital Estring is a non-formulary medicine Colchester Hospital / NEECCG Estring is considered a formulary choice (albeit very rarely utilised) 08.02.03 |
Ofatumumab injection |
| 11.03.01 |
Ofloxacin 0.3% Ophthalmic |
Suitable for milder infections 04.02.01 |
Olanzapine tabs, orodispersible tabs |
| 08.02.04 |
Olaparib caps |
Available as tabs and caps which are not interchangeable due to differences in bioavailability See below for further information 12.01.03 |
Olive Oil Ear Drops |
Available OTC 11.04.02 |
Olopatadine 1mg/ml Opatanol® |
| 03.04.02 |
Omalizumab Xolair® |
| 13.05.03 |
Omalizumab |
| 05.03.03.02 |
Ombitasvir/ paritaprevir/ ritonavir Viekirax® |
| 02.12 |
Omega-3-Acid Ethyl Esters Omacor® |
Ipswich Hospital Treatment initiation via the Lipid clinic only Secondary prevention of cardiovascular disease and in hypertriglyceridaemia (patients initiated prior to Feb 2009 may be continued) Colchester Hospital Omacor treatment is considered non-formulary. Colchester Hospital does not have a specialist lipid clinic. North East Essex CCG has a scheme to encourage de-prescribing (when appropriate) of this treatment which is classed as a "Drug of Limited Clinical Value". 01.03.05 |
Omeprazole caps |
Both oral omeprazole and oral lansoprazole are utilised without any real preference being specified. 01.03.05 |
Omeprazole IV |
Ipswich Hospital Intravenous omeprazole is restricted to Paediatric patients only. Colchester Hospital Intravenous omeprazole is the formulary injectable Proton-Pump-Inhibitor for both adults and paediatrics. 04.06 |
Ondansetron tablets, injection, suppositories,orodispersible films |
MHRA: Small increased risk of oral clefts following use in the first 12 weeks of pregnancy Traffic light information
04.09.01 |
Opicapone |
Traffic light information
Colchester Hospital Opicapone is considered a non-formulary medicine 09.02.01.02 |
Oral Rehydration Salts Electrolade® |
Can be bought OTC 04.05.01 |
Orlistat |
Used as an adjunct in the management of obesity in patients with
OR
Treatment with orlistat may also be used to maintain weight loss rather than to continue to lose weight. Discontinuation of treatment with orlistat should be considered after 12 weeks if weight loss has not exceeded 5% since the start of treatment. 04.09.02 |
Orphenadrine |
| 08.02.04 |
Osimertinib tabs |
| 12.01.01 |
Otomize Dexamethasone ,Acetic acid and Neomycin |
| 08.01.05 |
Oxaliplatin |
| 11.11 |
Oxybuprocaine 0.4% |
Single use eye drops 07.04.02 |
Oxybutynin |
| 07.04.02 |
Oxybutynin Hydrochloride patch |
Reserved for patients who cannot tolerate oral medication 04.07.02 |
Oxycodone MR tabs |
Only if morphine is not tollerated or ineffective Once daily preparation has not been approved for use Prescribe by brand
04.07.02 |
Oxycodone IR capsules |
Hospital only guidanceNot for inpatient use (risk of mix up with MR tablets) 04.07.02 |
Oxycodone injection |
Available as
04.07.02 |
Oxycodone liquid |
Available as
13.06.03 |
Oxytetracycline |
| 13.06.03 |
Oxytetracycline |
| 07.01.01 |
Oxytocin IV injection |
Active management of the 3rd stage of labour Initial management of postpartum haemorrhage (PPH) 07.01.01 |
Oxytocin IV infusion |
Induction and augmentation of labour Postpartum Haemorrhage (PPH) 09.06.02 |
Pabrinex® Vitamin B and C |
| 08.01.05 |
Paclitaxel |
| 08.01.05 |
Paclitaxel - Albumin Bound Formulation Abraxane® |
| 08.03.04.01 |
Palbociclib Ibrance |
| 04.02.02 |
Paliperidone depot |
MHRA:Risk of intraoperative floppy iris syndrome in patients undergoing cataract surgery 01.09.04 |
Pancrex® V powder, caps |
| 15.01.05 |
Pancuronium injection |
| 08.01.05 |
Panitumumab Vectibix® |
| 08.01.05 |
Panobinostat Farydak® |
| 01.03.05 |
Pantoprazole IV |
Hospital only guidancePrescribing information.On endoscopist recommendation only
or
Step down to oral Omeprazole once complete. NOTE: Pantoprazole IV is not currently utilised at Colchester Hospital and is considered Non-Formulary at this site. Intravenous omeprazole is the preferred injectable Proton-Pump-Inhibitor at Colchester. 20 |
PAPAVERINE 60mg in 1ml injection |
Available for accidental injection of thiopentone 04.07.01 |
Paracetamol |
Can be bought OTC 04.07.01 |
Paracetamol suspension |
Can be bought OTC Available as
Some preparations contain sorbitol- can cause diarrhoea 04.07.01 |
Paracetamol suppositories |
Note - the 1g suppositories are very expensive and are not recommended for use. Only to be used if tablets/liquid not appropriate; and as a possible alternative if the IV route (if unavailable) 04.07.01 |
Paracetamol soluble tabs |
Can be bought OTC Caution: high salt content 04.07.01 |
Paracetamol injection |
| 04.07.02 |
Paracetamol and codeine Co-codamol® 8/500 |
Can be bought OTC (max 3 days usage) Longer courses should be prescribed 04.07.02 |
Paracetamol and codeine Co-codamol® 30/500 |
Ipswich Hospital The combination formulation is considered Non-formulary. Treatment must be prescribed as the individual components.
Colchester Hospital Co-codaml 30/500 is considered formulary with no requirement to prescribe by seperate ingredients. 04.08.02 |
Paraldehyde enemas |
Ipswich Hospital and Colchester Hospital The use of paraldehyde to treat status epilepticus within the paediatric setting is an agreed treatment option 20 |
Paraldehyde / olive oil 50/50 Enema |
| 09.03 |
Parenteral Nutrition (TPN or PN) |
| 04.03.03 |
Paroxetine tabs, liquid |
| 20 |
Patent blue V 2.5% solution |
| 08.01.05 |
Pazopanib tabs |
| 14.04 |
Pediacel ® |
| 08.02.04 |
Peginterferon Alfa Pegasys® |
| 08.02.04 |
Peginterferon Beta-1a Plegridy® |
| 08.01.05 |
Pembrolizumab injection |
| 08.01.03 |
Pemetrexed injection |
| 10.01.03 |
Penicillamine |
| 08.01.05 |
Pentostatin injection |
| 01.02 |
Peppermint Oil |
Available OTC 01.01.02 |
Peptac ® |
| 04.08.01 |
Perampanel Fycompa® |
Ipswich Hospital Formulary Medicine - Indicated for the adjunctive treatment of partial-onset seizures with or without secondarily generalised seizures in adult and adolescent patients from 12 years of age with epilepsy. Colchester Hospital Perampanel is a non-formulary medicine. Therefore, treatment would not be initiated within the acute Trust, but if necessary to ensure patient care, existing therapy would be continued on (and supplies purchased if appropriate). 11.11 |
Perfluorodecalin liquid |
F-Decalin® 04.09.01 |
Pergolide |
Ipswich Hospital Pergolide is considered a formulary medicine
Colchester Hospital Pergolide is considered non-formulary 13.10.04 |
Permethrin 5% Cream |
Can be bought OTC 13.10.04 |
Permethrin 5% cream |
Can be bought OTC 08.01.05 |
Pertuzumab Perjeta® |
| 04.07.02 |
Pethidine injection |
| 15.01.04.03 |
Pethidine injection |
| 04.03.02 |
Phenelzine tabs |
Phenelzine is a rarely prescribed and specialist treatment within Mental Health. It would not be initiated within the acute hospitals at Ipswich and Colchester but existing patients admitted to the organisation would have their treatment continued; and supplies procured accordingly if necessary. 02.08.02 |
Phenindione |
| 04.08.01 |
Phenobarbital |
| 04.08.01 |
Phenobarbital alcohol free mixture |
Initiation in neonates only. 04.08.01 |
Phenobarbital injection |
Note: phenobarbital injection is also occasionally utilised subcutaneously to treat seizures within the palliative care setting 01.07.03 |
Phenol, Oily |
Not suitable for nut allergy sufferers Either arachis (peanut) or almond oil is used depending on the source of the product 02.05.04 |
Phenoxybenzamine Hydrochloride |
Hypertension in phaeochromocytoma 20 |
Phenylbutazone 100mg |
| 02.07.02 |
Phenylephrine |
Hospital ITU or anaesthesia only 11.10 |
Phenylephrine Hydrochloride |
Available as
04.08.01 |
Phenytoin |
100mg solid dosage form is equivalent to 90mg (15ml) liquid 04.08.02 |
Phenytoin injection |
Hospital only guidancePhenytoin naive patientsEnsure loading dose is calculated correctly Once loaded 100mg TDS may be prescribed Patients already on phenytoinNo loading dose is required 100mg TDS may be prescribed PAL filter may remain in situ for upto 96 hours 03.09.01 |
Pholcodine Linctus, BP |
For hospital inpatient use. Please recommend OTC in community 09.05.02.01 |
Phosphate Polyfusor ® |
| 09.05.02.01 |
Phosphate supplements Phosphate-Sandoz® |
| 01.06.04 |
Phosphates (Rectal) Fleet® Ready to use Enema |
| 09.06.06 |
Phytomenadione tab/caps/injection |
Preparation of choice for anticoagulant induced haemorrhage 20 |
Phytomenadione (Konakion®) 10mg capsules/tablets |
Preparation should only be used if licensed Vitamin K is not available Please note prices between tablets and capsules may vary and the formulation with the lowest acquisition cost should be used 01.06.05 |
Picolax Sodium picosulphate/ magnesium citrate |
| 11.06 |
Pilocarpine eye drops |
Available as
13.05.03 |
Pimecrolimus cream |
| 06.01.02.03 |
Pioglitazone |
|
In view of the above MHRA alerts, the use of pioglitazone treatment is limited. New patients should ideally not be initiated on therapy; existing patients will continue treatment after appropriate clinical review. 04.02.02 |
Pipotiazine Palmitate |
NEECCG Pipotiazine Palmitate is non-formulary 03.11 |
Pirfenidone Esbriet® |
Initiated by tertiary centre 10.03.02 |
Piroxicam 0.5% gel |
Ipswich Hospital Piroxicam 0.5% gel is a formulary medicine Colchester Hospital Piroxicam 0.5% gel is a non-formulary medicine 04.07.04.02 |
Pizotifen |
Specialist recommendation only - evidence of its efficacy is limited 09.08.01 |
PKU 2 gel Strensiq® |
| 09.08.01 |
PKU gel Strensiq® |
| 14.04 |
Pneumococcal polysaccharide conjugate vaccine (adsorbed) Prevenar 13® |
| 14.04 |
Pneumococcal polysaccharide conjugate vaccine (adsorbed) Synflorix® |
| 11.11 |
Polihexanide 0.02% (PHMB) |
Unlicensed special Preservative free eye drops 14.04 |
Poliomyelitis Vaccine Inactivated (Salk) |
| 14.04 |
Poliomyelitis Vaccine Live (oral) |
| 06.01.06 |
Polycal ® |
| 20 |
Polyhexyethylene (Polihexanide) Biguanide 0.05% Eye drops |
| 14.04 |
Polysaccharide Typhoid Vaccine Typherix® |
| 14.04 |
Polysaccharide vaccine for injection Typhim Vi® |
| 14.04 |
Polysaccharide vaccine with hepatitis A vaccine |
| 13.09 |
Polytar ® |
Can be bought OTC 11.08.01 |
Polyvinyl Alcohol 1.4% eye drops |
Can be bought OTC
NHS North East Essex CCG - Polyvinyl alcohol eye drops are considered a non-formualry medicine. 08.02.04 |
Pomalidomide |
| 03.05.02 |
Poractant Alfa Curosurf® |
| 11.99.99.99 |
Potassium Ascorbate (Ascorbic acid) |
IHT Ophthalmology Consultant Severe chemical burns are thankfully rare Patients need to replenish the ascorbate that disappears in alkali injuries to prevent the cornea melting. They also need sodium Citrate to reduce neutrophil activity again protecting against melting. They also get lots of topical steroid and may need surgery but it’s the availability of the rare drops that often impact the prognosis.
Within 12 hours of injury patients need:
09.02.01.01 |
Potassium Chloride Sando-K® |
One tablet = 12mmol potassium 09.02.01.01 |
Potassium Chloride Kay-Cee-L® |
One ml = 1mmol potassium 09.02.02.01 |
Potassium Chloride and Glucose Intravenous Infusion |
| 09.02.02.01 |
Potassium Chloride and Sodium Chloride Intravenous Infusion |
| 09.02.02.01 |
Potassium Chloride Concentrate (Sterile) |
09.02.02.01 |
Potassium Chloride, Sodium Chloride and Glucose Intravenous Infusion |
| 07.04.03 |
Potassium Citrate |
| 13.11.06 |
Potassium Permanganate Permitabs® |
PSA:Risk of death or serious harm from accidental ingestion of potassium permanganate preparations 11.11 |
Povidone iodine 5% |
Single use eye drops 11.03.01 |
Povidone iodine 5% preservative free eye drops |
| 04.09.01 |
Pramipexole tabs, MR tabs |
| 02.09 |
Prasugrel |
| 20 |
Praziquantel 500mg tablets |
| 01.05.02 |
Prednisolone retention enema |
| 01.05.02 |
Prednisolone tablets |
Joint guidanceEnteric coated tablets are not approved for use within the acute Trust and throughout the CCGs Prednisolone 25mg tablets are not approved for routine use (due to high cost) but may be utilised in rare patients requiring daily doses of 50mg daily (or more) to reduce tablet load Prednisolone soluble tablets are considered non-formulary due to their high cost and the fact that normal prednislone tablets can be crushed and dispersed to good effect 06.03.02 |
Prednisolone tablets |
Enteric coated tablets are not approved for use within the acute Trust and throughout the CCGs Prednisolone 25mg tablets are not approved for routine use (due to high cost) but may be utilised in rare patients requiring daily doses of 50mg daily (or more) to reduce tablet load Prednisolone soluble tablets are considered non-formulary due to their high cost and the fact that normal prednislone tablets can be crushed and dispersed to good effect 10.01.02.02 |
Prednisolone |
| 11.04.01 |
Prednisolone eye drops |
Available as
Prednisolone 0.5% is a mild steroid used for a wide range of occular surface diseases. 04.07.03 |
Pregabalin |
Traffic light information
14.04 |
Prevenar 13 ® |
| 15.02 |
Prilocaine Hydrochloride 1% injection |
| 04.08.01 |
Primidone |
| 20 |
Probenecid 500mg tablets |
| 08.01.05 |
Procarbazine caps |
| 04.06 |
Prochlorperazine injection |
Caution: can cause extrapyramidal side effects. Increased risk of drug-induced parkinsonism in the elderly particularly after prolonged use. 04.06 |
Prochlorperazine tablets,buccal tablets |
Tablets available as
Buccal tablets available as
Caution: can cause extrapyramidal side effects. Increased risk of drug-induced parkinsonism in the elderly particularly after prolonged use. 04.09.02 |
Procyclidine injection |
| 04.09.02 |
Procyclidine tabs, liquid |
| 06.04.01.01 |
Progynova HRT |
| 06.05.01 |
Progynova fertility |
Fertility monitoring unit only |
06.06.02 |
Prolia® Denosumab |
MHRA:Osteonecrosis of the external auditory canal MHRA: Osteonecrosis of the jaw Note two different brands Prolia is indicated for
For osteoporosis-NICE TA204 Ipswich Hospital/IESCCG Denosumab (for osteoporosis) is considered a "hospital-only" medicine Colchester Hospital/NEECCG Denosumab (for osteoporosis) is available for Primary Care prescribing under a Shared Care Agreement 04.06 |
Promethazine Hydrochloride Phenergan |
Mixed formulary: Blue: for insomnia, N&V, vertigo, labyrinthine disorders; Green: for mental health indication NON-FORMULARY: for motion sickness and allergies (OTC)
02.03.02 |
Propafenone |
| 11.11 |
Propamidine 0.1% Brolene |
| 15.01.01 |
Propofol |
Available as
02.04 |
Propranolol |
| 04.07.04.02 |
Propranolol |
Other beta blockers without partial agonism may also be used e.g. atenolol [unlicensed indication] and metoprolol. 06.02.02 |
Propylthiouracil |
| 13.02.02 |
Proshield Plus cream & spray |
For severe moisture excoriation or Only if LBF spray tried and failed Can be used as an alternative to paraffin based products
02.08.03 |
Protamine Sulphate |
Haematology approval required 06.05.01 |
Protirelin Thyrotropin-releasing hormone |
For TRH test 11.11 |
Proxymetacaine 0.5% |
Single use eye drops 01.06.07 |
Prucalopride Resolor® |
Treatment of chronic constipation in women 20 |
Pyrazinamide tablets 500mg |
| 10.02.01 |
Pyridostigmine Bromide tabs, MR tabs |
| 20 |
PYRIDOXAL PHOSPHATE Tablets 50 mg |
| 09.06.02 |
Pyridoxine Hydrochloride |
| 04.02.01 |
Quetiapine immediate release |
MR tablets are non-formulary Primary care guidanceSwitching from MR to IRFor patients prescribed MR tablets consider switching to immediate release. Please see below for guidance on switching and patient information leaflet 06.07.01 |
Quinagolide |
Specialist initiation only 10.02.02 |
Quinine |
MHRA:Reminder of dose-dependent QT-prolonging effects; updated medicine interactions 03.02.01 |
Qvar Beclometasone |
Prescribe by brand Avaiable as
Licensed for adults and children >12 years QVAR is approximately half the dose of clenil 14.04 |
Rabies vaccine Rabipur® |
| 14.04 |
Rabies vaccine |
| 06.04.01.01 |
Raloxifene Hydrochloride |
| 05.03.01 |
Raltegravir Isentress ® |
| 08.01.03 |
Raltitrexed injection |
| 02.05.05.01 |
Ramipril |
| 11.99.99.99 |
Ranibizumab 10mg/ml Lucentis® |
| 01.03.01 |
Ranitidine tabs |
Available OTC 01.03.01 |
Ranitidine injection 25mg/ml |
| 01.03.01 |
Ranitidine suspension 75mg/5ml |
Reserved for patients with swallowing difficulties or paediatrics 15.01.09 |
Ranitidine tablets, injection |
| 02.06.03 |
Ranolazine Ranexa® |
add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled or intolerant to first-line antianginal therapies (such as beta-blockers and/or calcium antagonists). 22 |
Rarely Used or Urgent Access Drugs |
04.09.01 |
Rasagiline |
Must only be initiated by Specalists/Consultants working within Neurology. 10.01.04 |
Rasburicase |
Oncology & Haematology consultants only 04.03.04 |
Reboxetine Edronex® |
Reboxetine is a rarely prescribed and specialist treatment within Mental Health. It would not be initiated within the acute hospitals at Ipswich and Colchester but existing patients admitted to the organisation would have their treatment continued; and supplies procured accordingly if necessary. 01.03 |
Regimen 1 |
Interactions with clarithromycin Inhibits metabolism of theophylline; consider reducing total daily dose of theophylline by up to 50% Increased risk of myopathy with statins; avoid concomitant use 01.03 |
Regimen 2 |
Penicillin allergic patients
Interactions with clarithromycin Inhibits metabolism of theophylline; consider reducing total daily dose of theophylline by up to 50% Increased risk of myopathy with statins; avoid concomitant use 01.03 |
Regimen 3 |
Gastro recommended regimenRegimen 3 may consist of a combination of the drugs listed. Doses,duration and any further information will be provided by a gastroenterologist
08.01.05 |
Regorafenib tabs |
| 03.02.02 |
Relvar Ellipta 184/22 Fluticasone furoate & vilanterol |
On specialist recommendation only (for asthma) 03.02.02 |
Relvar Ellipta 92/22 Fluticasone furoate & vilanterol |
Reserved for patients intolerant to Fostair or Flutiform 03.02.03 |
Relvar Ellipta 92/22 Fluticasone furoate & vilanterol |
Licensed for adults >18 years only (for COPD) 15.01.04.03 |
Remifentanil |
May have a role in haemodynamically challenging patients and in procedures not associated with severe post-op pain 14.04 |
Repevax ® |
| 09.02.01.01 |
Resonium A® Polystyrene Sulphonate Resins |
Contains sodium rather than calcium – useful for where there is hypercalcaemia as well hyperkalaemia 04.08.01 |
Retigabine |
Discontinued by manufacturer, see below for further information. 14.04 |
Revaxis ® |
| 24.01 |
Riamet tabs |
Held at Colchester Hospital Antimalarial 08.03.04.01 |
Ribociclib tabs |
| 20 |
Riboflavin (Vitamin B2) tablets 200mg |
| 11.11 |
Riboflavin 0.1% eye drops MedioCROSS D |
As per NICE interventional procedures guidance 466 05.01.07 |
Rifaximin Targaxan® |
Reduction in recurrence of episodes of overt hepatic encephalopathy in patients ≥ 18 years of age 05.03.01 |
Rilpivirine hydrochloride Edurant® |
| 11.04.01 |
Rimexolone 1% |
Parallel import only Not readily available 09.02.02.01 |
Ringer's Solution for Injection |
| 13.05.03.02 |
Risankizumab Skyrizi |
| 06.06.02 |
Risedronate |
Treatment has limited use in practice - it is second line treatment only utilised if patients are intolerant to alendronic acid therapy 04.02.01 |
Risperidone tabs |
MHRA:Risk of intraoperative floppy iris syndrome in patients undergoing cataract surgery 04.02.02 |
Risperidone Risperdal Consta® |
MHRA:Risk of intraoperative floppy iris syndrome in patients undergoing cataract surgery 05.03.01 |
Ritonavir Norvir® |
MHRA: Interaction with levothyroxine leading to reduced thyroxine levels 08.02.03 |
Rituximab |
Hospital only guidanceMust be prescribed by brand name See IHT newsletter below for further information Existing patientsContinue using MabThera® unless a switch has been agreed (NB-subcutaneous MabThera will remain the same in NHL) New patientsNew patients requiring IV rituximab will be prescribed Truxima®. See IHT newsletter below for further information 10.01.03 |
Rituximab (rheumatology) |
Prescribing rituximab at Ipswich and Colchester hospitals
02.08.02 |
Rivaroxaban |
|
MHRA: Reminder that 15 mg and 20 mg tablets should be taken with food Traffic light information
04.09.01 |
Rivastigmine |
Capsules licensed for Parkinson’s dementia. Patch to be considered (off label) if patient unable to tolerate GI side effects or poor swallow. May also improve symptoms of delirium/hallucinations associated with Parkinson's dementia. 04.11 |
Rivastigmine |
Initiated and stabilised by secondary care 15.01.05 |
Rocuronium injection |
| 03.03.03 |
Roflumilast Daxas® |
| 09.01.04 |
Romiplostim injection |
| 04.09.01 |
Ropinirole tabs, MR tabs |
| 15.02 |
Ropivacaine Hydrochloride 2mg/ml infusion |
| 02.12 |
Rosuvastatin |
3rd Line option when patients are unable to tolerate simvastatin or atorvastatin. Rosuvastatin patients admitted to hospital falling outside of this guidance will have their treatment reviewed to atorvastatin in line with the agreed Pharmacy Therapeutic Substitution process. 14.04 |
Rotavirus vaccine Rotarix® |
| 04.09.01 |
Rotigotine patches |
Rotigotine patches are very expensive and must be issued sparingly when being utilised within the acute setting as a temporary alternative to oral Parkinsons therapy in Nil-by-Mouth patients. 08.01.05 |
Ruxolitinib tabs |
| 02.05.05.02 |
Sacubitril valsartan Entresto® |
Joint guidanceCriteria for useFor treating symptomatic chronic heart failure with reduced ejection fraction, only in people who meet the following criteria:
Initial supply, monitoring and dose titration by hospital, moved to primary care once stable 04.09.01 |
Safinamide |
This is a restricted drug available for specialist consultant initiation only on both hospital sites. Prescribing should remain in secondary care until such a time when the patient becomes stable on treatment. 03.01.01.01 |
Salbutamol DPI- Easyhaler® |
Not stocked at IHT 03.01.01.01 |
Salbutamol intravenous |
| 03.01.01.01 |
Salbutamol 2.5mg and 5mg nebulisers |
Only if patient unable to use inhalers / patients with severe disease. 03.01.01.01 |
Salbutamol MDI |
| 13.07 |
Salicylic Acid Duofilm® |
Caution with diabetic patients or others with poor circulation, care and close monitoring is needed. Counsel patient that topical salicylic acid may require administration for up to 12 weeks and can cause local skin irritation. 13.08.01 |
Salicylic acid 2% ointment |
Only on advice from secondary care/integrated dermatology service |
09.05.01.01 |
Sandocal-1000 ® |
| 05.03.01 |
Saquinavir Invirase® |
| 10.01.03 |
Sarilumab |
| 06.01.02.03 |
Saxagliptin |
For treatment continuation or new initiations requiring monotherapy 01.07.02 |
Scheriproct ® ointment, suppositories |
Short term use only 13.05.02 |
Sebco ® Coal tar solution 12% |
Can be bought OTC Coal tar shampoos should not be used alone for people who have severe scalp psoriasis 10.01.03 |
Secukinumab |
| 13.05.03.02 |
Secukinumab |
| 04.09.01 |
Selegiline Hydrochloride tabs, lyophilisate |
10mg tablet equivalent to 1.25mg lyophilisate 06.01.02.03 |
Semaglutide Omzempic |
Initial supply of 4 weeks to be made by the hospital with extra information provided to the patient by the specialist (see below) 06.01.01.02 |
Semglee® Insulin glargine |
For new initiations for patients requiring glargine Available as:
01.06.02 |
Senna tabs, syrup |
Available OTC 03.02.02 |
Seretide 50 Fluticasone propionate and salmeterol |
Paediatric use only
04.03.03 |
Sertraline tabs |
| 09.05.02.02 |
Sevelamer Carbonate Renvela® |
Hospital only guidanceTherapeutic substitutionPatients using sevelamer hydrochloride (Renagel®) can be therapeutically substituted to sevelamer carbonate (Renvela®) without any dose ajustment 15.01.02 |
Sevoflurane |
Restricted usage only 11.11 |
SF6 |
Arecole ® SF6 07.04.05 |
Sildenafil |
| 11.11 |
Silicone oil |
| 13.10.01.01 |
Silver Sulfadiazine Flamazine® |
For wound care 05.03.03.02 |
Simeprevir Olysio® |
| 03.09.02 |
Simple Linctus, BP |
Available OTC 02.12 |
Simvastatin |
Interactions with simvastatin
08.02.04 |
Siponimod Mayzent Tablets |
| 08.02.02 |
Sirolimus Rapamune® |
Immunosuppression in liver and kidney allograft recipients Traffic light information
06.01.02.03 |
Sitagliptin Januvia® |
Treatment would not usually be initiated within the acute Trust - existing treatment would be continued on if appropriate 13.02.01.01 |
Soap substitutes |
Click here to see preparations used as soap substitutes 20 |
Sodium benzoate |
Available as
09.02.01.03 |
Sodium Bicarbonate caps,tabs |
| 09.02.01.03 |
Sodium Bicarbonate infusion |
| 12.01.03 |
Sodium Bicarbonate |
Available OTC 03.01.05 |
Sodium Chloride |
| 09.02.01.02 |
Sodium Chloride Slow Sodium® |
| 12.02.02 |
Sodium chloride 0.9% |
Can also be bought OTC 03.07 |
Sodium chloride 3% (Hypertonic) |
Ipswich Hospital Formulary medicine - only to be used if patients are sensitive to 7% preparation Colchester Hospital Sodium chloride 3% (hypertonic) is considered to be non-formulary 11.08.01 |
Sodium Chloride 5% |
Available as
20 |
Sodium chloride 5% eye oint |
| 03.07 |
Sodium chloride 6% (hypertonic) MucoClear® |
Ipswich Hospital MucoClear is a non-formulary medicine Colchester Hospital Mucoclear is considered a formulary medicine 03.07 |
Sodium chloride 7% (Hypertonic) |
| 09.02.02.01 |
Sodium Chloride and Glucose Intravenous Infusion |
| 09.02.02.01 |
Sodium Chloride Intravenous |
| 01.06.04 |
Sodium Citrate micro-enema |
Available OTC 11.99.99.99 |
Sodium Citrate |
IHT Ophthalmology Consultant Severe chemical burns are thankfully rare Patients need to replenish the ascorbate that disappears in alkali injuries to prevent the cornea melting. They also need sodium Citrate to reduce neutrophil activity again protecting against melting. They also get lots of topical steroid and may need surgery but it’s the availability of the rare drops that often impact the prognosis.
Within 12 hours of injury patients need:
01.01.01 |
Sodium citrate mixture |
Hospital inpatient use for acid aspiration prophylaxis only. 01.01.02 |
Sodium citrate 8.8% (0.3M) |
Maternity use only 06.06.02 |
Sodium Clodronate |
Specialist initiated Bone pain only 11.04.02 |
Sodium Cromoglicate |
Can be bought OTC 09.01.01.01 |
Sodium Feredetate Sytron® |
| 11.08.01 |
Sodium Hyaluronate |
Can be bought OTC Available as
11.11 |
Sodium hyaluronate intra-occular solution |
Available as
11.11 |
Sodium hyaluronate 2%/sorbitol 4% intra-occular solution |
For corneal surgery
11.08.01 |
Sodium Hyaluronate and trehalose Thealoz Duo |
Can be bought OTC 20 |
Sodium phenylbutyrate |
Available as
01.06.02 |
Sodium Picosulfate liquid |
| 04.08.01 |
Sodium Valproate EC tabs, MR tabs, liquid |
|
MHRA: Pregnancy prevention programme: updated educational materials Traffic light information
Primary care guidanceIdentification and review of patientsPrescribers in primary care should use searches available on the clinical system to identify patients of childbearing age using valproate. Patients who have not had a Risk Acknowledgment Form filled out should seek specialist advice or refer where appropriate IESCCG-Please see guidance below for further information 04.08.01 |
Sodium Valproate Intravenous |
|
MHRA:Pregnancy Prevention Programme materials online If patients are being converted from oral to IV use the same dose 09.02.01.01 |
Sodium zirconium cyclosilicate Lokelma ® |
Discontinue when potassium less than or equal to 5mmol/L Sodium zirconium cyclosilicate (Lokelma®) can be used in outpatient care for patients with persistent hyperkalaemia and chronic kidney disease stage 3b to 5 or heart failure, if they:
05.03.03.02 |
Sofosbuvir Sovaldi® |
| 05.03.03.02 |
Sofosbuvir/velpatasvir/voxilaprevir Vosevi |
| 12.01.01 |
Sofradex Dexamethasone, Framycetin and Gramicidin |
| 07.04.02 |
Solifenacin Vesicare® |
Ipswich Hospital Solifenacin is considered a non-formulary medicine Colchester Hospital / NEECCG Solifenacin is considered a formulary choice (second line treatment) 06.05.01 |
Somatropin |
Traffic light information
08.01.05 |
Sorafenib tabs |
| 02.04 |
Sotalol |
| 11.08.01 |
Soybean oil unit dose eye drops Emustil® |
Ipswich Hospital Emustil 7% preservative free drops are non-formulary Colchester Hospital Emustil 7% preservative free drops are considered a formulary medicines choice 03.01.05 |
Space Chamber Plus Compact® |
Available with a mask. Check spacer fits prescribed inhaler(s). Dishwasher safe 02.02.03 |
Spironolactone |
| 20 |
SPIRONOLACTONE Liquid |
Available as
03.01.05 |
Standard range peak flow meter Airzone® |
Specify as "standard range peak flow meter" on prescription 05.03.01 |
Stavudine Zerit® |
| 07.04.04 |
Suby G Catheter Patency Solutions |
| 01.03.03 |
Sucralfate tablets |
| 01.03.03 |
Sucralfate suspension |
Note: sucralfate liquid is cheaper than the liquid and should be used in preference to a tablet where possible. 01.03.03 |
Sucralfate enema (unlicensed) |
For radiation proctitis 15.01.09 |
Sucralfate tablets |
09.05.02.02 |
sucroferric oxyhydroxide tabs |
Hospital only guidanceInitiationOnly for dialysis patients as per SPC and only as a third line agent in those patients unable to tolerate or adhere to the large tablet burden of sevelamer and lanthanum carbonate. 15.01.06 |
Sugammadex injection |
| 01.05.01 |
Sulfasalazine tabs, suspension, E/C tabs |
Joint guidanceOnly use if intolerant to non-enteric coated tablets Patients can be switched without having to contact the consultant if shared care has been initiated with non-EC tablets 10.01.03 |
Sulfasalazine tabs,suspension, E/C tabs |
Traffic light information
Joint guidanceOnly use if intolerant to non-enteric coated tablets Patients can be switched without having to contact consultant if shared care has been initiated with non-EC tablets 04.02.01 |
Sulpiride tablets, liquid |
Sulpiride is a specialist treatment within Mental Health. It would not be initiated within the acute hospitals at Ipswich and Colchester but existing patients admitted to the organisation would have their treatment continued; and supplies procured accordingly if necessary. 04.07.04.01 |
Sumatriptan tabs,nasal spray, injection |
Consider combining 5HT1 receptoragonist with either NSAID or paracetamol 08.01.05 |
Sunitinib caps |
| 13.08.01 |
Sunsense ® Ultra |
| 09.03 |
Supplementary Preparations Addiphos® |
| 09.03 |
Supplementary Preparations Additrace® |
| 15.01.05 |
Suxamethonium Chloride injection |
| 08.02.02 |
Tacrolimus |
Must be prescribed by brand Immunosuppression in liver and kidney allograft recipients Traffic light information
Available as
13.05.03 |
Tacrolimus ointment |
MHRA:Possible risk of malignancies Available as
08.02.02 |
Tacrolimus modified release Envarsus |
For prophylaxis of transplant rejection in adult kidney transplant patients ONCE DAILY tacrolimus dosing Patients maintained on Prograf or Advograf will require dose conversion when switching to Envarsus. This would be equivalent to 30% less than the Prograf or Advograf maintenance dose 07.04.05 |
Tadalafil once daily |
Traffic light information
IESCCG policy: For the ‘green’ indication, tadalafil should be initiated by the hospital specialist and a 2 week prescription given. After 2 weeks the GP can then continue prescribing. The patient should be reviewed by the hospital specialist at 3 months and if tadalafil once daily has been effective, the specialist should advise the GP to change the patient to PRN sildenafil. The hospital specialist should explain the change to patient. If tadalafil has not been effective - the specialist should advise the GP on alternative treatments. This may include continuing tadalafil once daily for a further 6-9 months (this would be a very small number of patients). Tadalafil daily should not be continued for longer than a year in any patient. 07.04.05 |
Tadalafil prn |
| 11.06 |
Tafluprost 15mcg/ml eye drops |
Available as preservative free drops 11.06 |
Tafluprost and Timolol |
Ipswich Hospital The tafluprost/timolol combination eye drop is a formulary medicine choice - available as 15mcg per ml / 0.5% Colchester Hospital The tafluprost/timolol combination eye drop is a non-formulary medicine 20 |
TALC BP purified sterile |
Hospital only guidancePrescribing guidance08.03.04.01 |
Tamoxifen |
| 07.04.01 |
Tamsulosin |
| 04.07.02 |
Targinact (Oxycodone/Naloxone) Targinact® |
| 06.01.06 |
TEE 2+ |
Compatible strips
08.01.03 |
Tegafur with Uracil caps |
| 05.03.03.02 |
Telaprevir Incivo® |
| 04.01.01 |
Temazepam tablets, liquid |
Note liquid is expensive 08.01.05 |
Temozolomide caps |
| 08.01.05 |
Temsirolimus injection |
| 02.10.02 |
Tenecteplase Metalyse® |
For ED use only in selected patients with acute coronary occlusion when timely access to Primary Percutaneous Coronary Intervention (PPCI) is unavailable. 05.03.01 |
Tenofovir 245mg, Efavirenz 600mg and Emtricitabine 200mg Atripla® |
| 05.03.01 |
Tenofovir alafenamide, elvitegravir, cobicistat & emtricitabine Genvoya® |
| 05.03.03.01 |
Tenofovir disoproxil Viread |
Indicated for chronic hepatitis B infection. Also indicated for HIV infection in combination with other antiretroviral drugs 05.03.01 |
Tenofovir Disproxil Viread® |
Indicated for HIV infection in combination with other antiretroviral drugs. Also indicated for chronic hepatitis B infection. 05.03.03.01 |
Tenofovir Disproxil Viread® |
| 05.03.01 |
Tenofovir, cobicistat, elvitegravir & emtricitabine Stribild® |
| 02.05.04 |
Terazosin |
First dose effectFirst dose may cause collapse due to hypotensive effect (therefore should be taken at bedtime). Patient should be warned to lie down if symptoms such as dizziness, fatigue or sweating develop, and to remain lying down until the effects subside 07.04.01 |
Terazosin |
Restricted usage - terazosin is unlikely to be initiated within the acute Trust for urinary retention but existing therapy will be continued on if appropriate 13.10.02 |
Terbinafine 1% cream |
Can be bought OTC 13.10.02 |
Terbinafine tablets |
Primary care guidanceTreating Fungal Nail InfectionIf antifungal treatment is indicated, confirm diagnosis (positive microscopy or positive culture) via mycology result before initiating treatment It is not recommended to combine topical treatment and oral drug treatment. Usual course length 3 months Perform LFT prior to treatment and monitor periodically Amorolfine nail lacquer is available OTC for mild cases and for treatment of max. 2 nails. It should not be prescribed as there is a lack of evidence. 03.01.01.01 |
Terbutaline Nebulisers |
Reserved for patients intolerant or allergic to salbutamol where a patient is unable to use inhalers or has severe disease 03.01.01.01 |
Terbutaline DPI |
Reserved for patients intolerant or allergic to salbutamol. Licensed for adults and children >5 years 07.01.03 |
Terbutaline SC injection |
MHRA:Restricted use for tocolysis in premature labour Unlicensed use
08.02.04 |
Teriflunomide tabs |
| 06.06.01 |
Teriparatide injection |
For treatment of osteoporosis Ipswich Hospital/IESCCG Teriparatide is considered a hospital-only medicine ony - Hospital Rheumatology Consultant initiation only Colchester Hospital/NEECCG Teriparatide is available for prescribing within Primary Care under Shared Care Agreement 06.05.02 |
Terlipressin injection |
| 20 |
Terracortril (Oxytetracycline + Hydrocortisone) |
Overgranulation |
16.01 |
Test Flame |
06.04.02 |
Testogel Testosterone gel |
50mg/5g gel sachet 06.04.02 |
Testosterone injection Sustanon 250® |
| 06.04.02 |
Testosterone undecanoate Restandol Testocaps® |
| 06.04.02 |
Testosterone undecanoate Nebido® injection |
| 14.05.02 |
Tetanus immunoglobulin |
| 04.09.03 |
Tetrabenazine Xenazine® 25 |
Treatment must be initiated by a Neurology Specialist. 15.02 |
Tetracaine (Amethocaine) Ametop® 4% gel |
| 11.11 |
Tetracaine 1% |
Single use eye drops 06.05.01 |
Tetracosactide Synacthen® |
| 09.02.02.02 |
Tetrastarch Volulyte® |
| 08.02.04 |
Thalidomide caps |
| 20 |
Tham injection 7% |
| 09.06.02 |
Thiamine |
| 20 |
THIAMINE Injection 100 mg in 1mL |
| 15.01.01 |
Thiopental injection |
Papaverine HCl available for accidental intraarticular injection of thiopentone 08.01.01 |
Thiotepa injection |
| 06.05.01 |
Thyrotropin Alfa |
Restricted to oncology and endrocrinology use only 04.08.01 |
Tiagabine |
Ipswich Hospital Tiagabine is considered a formulary medicine Colchester Hospital Tiagabine is a non-formulary medicine. Therefore, treatment would not be initiated within the acute Trust, but if necessary to ensure patient care, existing therapy would be continued on (and supplies purchased if appropriate). 06.04.01.01 |
Tibolone |
| 02.09 |
Ticagrelor |
| 13.05.03.02 |
Tildrakizumab Ilumetri 100mg/ml injection |
| 11.06 |
Timolol |
Ipswich Hospital Available preparations are:
Note: 0.5% formulation not approved at Ipswich hospital Colchester Hospital Available preparations are:
11.06 |
Timolol 0.1% |
Low strength beta-blocker 08.01.03 |
Tioguanine caps, suspension |
| 03.01.02 |
Tiotropium Spiriva® Respimat |
On specialist recommendation (asthma)
02.09 |
Tirofiban |
Cardiology approval only 11.11 |
Tisseel glue |
Solutions for sealant 08.01.05 |
Tivozanib Capsules |
| 10.02.02 |
Tizanidine |
| 10.01.03 |
Tocilizumab |
MHRA: Rare risk of serious liver injury including cases requiring transplantation 01.05.03 |
Tofacitinib |
| 10.01.03 |
Tofacitinib |
| 04.09.01 |
Tolcapone |
Ipswich Hospital Tolcapone is a formulary medicine Colchester Hospital Tolcapone is considered a non-formulary medicine 07.04.02 |
Tolterodine modified release |
| 07.04.02 |
Tolterodine immediate release |
Use in preference to modified release where possible due to lower cost 06.05.02 |
Tolvaptan Jinarc® |
Very specialist use within Renal Services only - in strict accordance with the NICE guidance relating to the treatment of Autosomal Dominant Polycystic Kidney Disease 13.05.01 |
Topical corticosteroids |
Click here to see corticosteroids 13.05.02 |
Topical corticosteroids |
Click here to see corticosteroids Topical corticosteroids are only suitable for treating localized psoriasis. They should only be applied once daily. Very potent topical steroids under specialist supervision only 04.07.04.02 |
Topiramate |
Contra-indicated in pregnancy and in women of child-bearing potential for migraine prophylaxis if not using an effective method of contraception. Patients on long term treatment should be regularly weighed and monitored for continued weight loss. If clinically significant weight loss occurs, consider stopping treatment. Topiramate is associated with depression. 04.08.01 |
Topiramate |
| 08.01.05 |
Topotecan caps, injection |
| 06.04.02 |
Tostran Testosterone gel |
2% gel 06.01.01.02 |
Toujeo® Insulin Glargine |
Basal insulin Available as:
08.01.05 |
Trabectedin injection |
| 04.07.02 |
Tramadol caps, MR tabs |
Caution when using modified release preparations as some preparations are for once daily dosing 08.01.05 |
Trametinib tabs |
| 02.11 |
Tranexamic Acid |
| 12.03.04 |
Tranexamic Acid Mouthwash 5% |
For use in Radiotherapy or oncology 12.03.04 |
Tranexamic Acid Topical Solution |
For use in Palliative Care 08.01.05 |
Trastuzumab |
| 08.01.05 |
Trastuzumab emtansine |
| 11.06 |
Travoprost 40mcg/ml eye drop |
| 11.06 |
Travoprost and Timolol |
Available as 40mcg per ml / 0.5% 04.03.01 |
Trazodone tabs, caps, liquid |
Trazodone treatment would not be initiated within the acute Trust, but if necessary to ensure patient care, existing therapy would be continued on (and supplies purchased if appropriate Note: the liquid formulation is expensive and therefore must only be used in appropriate circumstances 03.02.03 |
Trelegy |
Components
Once daily dosing 08.01.01 |
Treosulfan caps, injection |
| 06.01.01.02 |
Tresiba® Insulin degludec |
Basal insulin Available as:
06.03.02 |
Triamcinolone acetonide intra-articular/ intramuscular injection |
Hospital only guidanceIndicationsFor adult use only. 10.01.02.02 |
Triamcinolone Acetonide Adcortyl® |
Note there are two brands May be used by intravitreal injection (unlicensed indication) 10.01.02.02 |
Triamcinolone Acetonide Kenalog® |
Note there are two brands 12.02.01 |
Triamcinolone Acetonide Nasacort® |
Ipswich Hospital Triamcinolone acetonide nasal spray (Nasocort) is non-formulary Colchester Hospital Triamcinolone acetonide nasal spray (Nasocort) is considered a formulary medicine 06.03.02 |
Triamcinolone hexacetonide injection |
For paediatric use only 04.02.01 |
Trifluoperazine tabs, liquid |
Trifluoperazine is a rarely prescribed and specialist treatment within Mental Health. It would not be initiated within the acute hospitals at Ipswich and Colchester but existing patients admitted to the organisation would have their treatment continued; and supplies procured accordingly if necessary. 08.01.03 |
Trifluridine with tipiracil tabs |
| 04.09.02 |
Trihexyphenidyl |
| 03.02.03 |
Trimbow |
Components
Twice daily dosing 13.04.04 |
Trimovate ® antifungal and antibacterial |
Currently only available as an unlicensed medicine
06.07.02 |
Triptorelin Decapeptyl SR ® |
Traffic light information
08.03.04.02 |
Triptorelin Gonapeptyl Depot® |
| 11.10 |
Tropicamide |
Hospital clinic use only Avaiable as
11.11 |
Tropicamide0.2mg/phenylephrine 3.1mg/lidocaine 10mg/ml intracameral injection |
Mydrane ® 07.04.02 |
Trospium immediate release |
Rarely used treatment but does not cross the blood-brain barrier so perhaps fewer central side effects compared to other antimuscarinics - second/third line treatment 07.04.02 |
Trospium MR |
Ipswich Hospital / NEECCG Trospium MR is considered a formulary medicine Colchester Hospital Trospium MR is considered a non-formulary medicine 11.11 |
Trypan blue Vioron® |
| 14.04 |
Typhoid Live Oral vaccine Vivotif® |
| 07.03.05 |
Ulipristal |
Can be used up to 120 hours after unprotected intercourse 13.02.01 |
Ultrabase ® |
Can be bought OTC
03.01.02 |
Umeclidinium Incruse Ellipta® |
Licensed for adults >18 years for COPD 03.01.04 |
Umeclidinium & vilanterol Anoro Ellipta® |
Licensed for adults >18 years for COPD 03.01.03 |
Uniphyllin® Continus |
Always prescribe by brand 02.10.02 |
Urokinase |
Used for clearing PICC line blockage Thrombolytic treatment of occluded central venous access devices including those used for haemodialysis See IHT guidance below 07.04.04 |
Urotainer Sodium chloride 0.9% |
| 01.09.01 |
Ursodeoxycholic acid tablets, liquid |
Initiated by specialist Avoid 500mg tabs due to higher cost Liquid reserved for patients with swallowing difficulties. 01.05.03 |
Ustekinumab Gastroenterology |
|
10.01.03 |
Ustekinumab Rheumatology |
| 13.05.03.02 |
Ustekinumab |
| 13.08.01 |
Uvistat ® |
| 07.04.05 |
Vacuum Pumps for erectile dysfunction |
Vacuum pumps listed in the Drug Tariff may be recommended by a specialist The products can ordered on an FP10 (ie prescribed "on the NHS") only if the patient meets the following criteria a) a man who is suffering from any of the following -
or (b) a man who is receiving treatment for renal failure by dialysis or (c) a man who has had the following surgery
If a patient has one of the above and is using the pump for the treatment of erectile dysfunction, the prescriber should endorse the FP10 with "SLS". Practices should ensure the patient has received counseling from the specialist on how to operate the pump. 06.04.01.01 |
Vagifem Estradiol |
| 05.03.02.02 |
Valganciclovir |
| 04.02.03 |
Valproic Acid Depakote® |
|
MHRA: Pregnancy prevention programme: updated educational materials Traffic light information
Primary care guidanceIdentification and review of patientsPrescribers in primary care should use searches available on the clinical system to identify patients of childbearing age using valproate. Patients who have not had a Risk Acknowledgment Form filled out should seek specialist advice or refer where appropriate IESCCG-Please see guidance below for further information 11.11 |
Vancomycin 1mg/0.1ml intravitreal injection |
Injection prepared for intravitreal use (pre-filled syringes available from pharmacy) 08.01.05 |
Vandetanib tabs |
See below for further information for educational material for the following areas
07.04.05 |
Vardenafil Levitra® |
| 04.10.02 |
Varenicline Champix® |
Smoking cessation-must have level 3 smoking cessation support 14.04 |
Varicella Zoster vaccine Zostavax® |
| 14.05.02 |
Varicella-Zoster immunoglobulin VZIG |
Only to be prescribed after consultation with an Ipswich Hospital microbiologist 14.04 |
Varicella-zoster vaccine Varilrix® |
| 14.04 |
Varicella-zoster vaccine Varivax® |
| 06.05.02 |
Vasopressin Argipressin |
Hospital use only - for organ preservation and critical care use 15.01.05 |
Vecuronium injection |
| 01.05.03 |
Vedolizumab |
| 13.08.02 |
Veil ® |
| 08.01.05 |
Vemurafenib tabs |
| 04.03.04 |
Venlafaxine MR caps |
Avoid MR tabs (higher cost) 04.03.04 |
Venlafaxine IR tabs |
| 02.06.02 |
Verapamil injection |
| 02.06.02 |
Verapamil modified release tablets, solution |
| 06.01.02.03 |
Victoza® Liraglutide |
Must be prescribed by brand 04.08.01 |
Vigabatrin |
| 08.01.04 |
Vinblastine Sulphate |
| 08.01.04 |
Vincristine Sulphate injection |
| 08.01.04 |
Vindesine Sulphate injection |
| 08.01.04 |
Vinflunine injection |
| 08.01.04 |
Vinorelbine caps |
| 08.01.05 |
Vismodegib caps |
| 09.06.07 |
Vitamin and mineral supplements Ketovite® |
Can be bought OTC Ketovite capsules, tablets and liquid are not interchangable 09.06.07 |
Vitamin and mineral supplements Forceval® |
Can be bought OTC 09.06.02 |
Vitamin B Tablets, Compound Strong |
| 03.01.05 |
Volumatic ® |
Available with a mask. Check spacer fits prescribed inhaler(s) 11.03.02 |
Voriconazole 1% |
This is a very specialist and restricted product prescribed only in specific circumstances. The voriconazole 1% drops product is an 04.03.03 |
Vortioxetine |
If a patient is admitted on this treatment and initiated by the mental health trust, Vortioxetine can continue. 02.08.02 |
Warfarin |
Primary care guidanceWarfarin supplyNote only 0.5mg,1mg,3mg are approved for local use There is a risk of overdose/underdose due to confusion between 0.5mg and 5mg tablets If patients are using 5mg tablets, consideration must be given to discontinue this strength and to prescribe 1mg and 3mg tablets to make up the required dose
Hospital only guidanceIpswich hospitalIHT (and WSH) only keep 1mg and 3mg. Patients requiring half mg doses will need 0.5mg strength prescribed and supplied in primary care following discharge Colchester hospitalThe 500microg (0.5mg) strength is available and considered a formulary medicine 09.02.02.01 |
Water for Injection |
| 06.06.02 |
XGEVA® Denosumab |
MHRA:Osteonecrosis of the external auditory canal MHRA: Osteonecrosis of the jaw Note two different brands XGEVA is indicated for
12.02.02 |
Xylometazoline Otrivine® |
Avaiable OTC Avaiable as
13.02 |
ZeroAQS ® |
Can be bought OTC 13.02.01 |
Zeroderm ® |
Can be bought OTC
Equivalent to Hydromol ointment (lanolin free) and Epaderm ointment 05.03.01 |
Zidovudine Retrovir® |
| 05.03.01 |
Zidovudine and lamivudine |
| 09.05.04 |
Zinc Sulphate |
Available as
06.06.02 |
Zoledronic Acid 5mg injection |
Note 2 different strengths of Zolendronic acid For osteoporosis and Paget's disease 06.06.02 |
Zoledronic Acid 4mg injection |
Note 2 different strengths of Zolendronic acid For oncology related indications 04.07.04.01 |
Zolmitriptan Tabs, orodispersable tabs, nasal spray |
Consider combining 5HT1 receptoragonist with either NSAID or paracetamol 04.01.01 |
Zolpidem tabs |
MHRA:Risk of drowsiness and reduced driving ability
Last line 'Z' drug to use
04.08.01 |
Zonisamide |
| 04.01.01 |
Zopiclone tabs |
| 04.02.01 |
Zuclopenthixol tablets |
Zuclopenthixol tablets are a rarely prescribed and specialist treatment within Mental Health. It would not be initiated within the acute hospitals at Ipswich and Colchester but existing patients admitted to the organisation would have their treatment continued; and supplies procured accordingly if necessary. 04.02.02 |
Zuclopenthixol Acetate |
| 04.02.02 |
Zuclopenthixol Decanoate |
| |